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1. INTRODUCTION 
 
1.1 Midbrain dopaminergic neurons  
Behind fundamental functions of the mammalian brain, such as fine motor 
integration, neuroendocrine hormone release, cognition, emotion, reward and 
memory resides the regulatory role of the catecholamine dopamine (DA). This 
neurotransmitter is produced and released by an anatomically and functionally 
heterogeneous class of neurons: the dopaminergic neurons.  
In the mammalian central nervous system (CNS) dopaminergic nuclei have a broad 
distribution and are located in the area A16 of the olfactory bulbs (Gudelsky and 
Moore 1976) area A17 of the retina (Djamgoz and Wagner 1992), areas A11-A15 of 
the diencephalon [e.g. hypothalamic arcuate nucleus (A12; Kizer et al. 1976) , sub-
parafascicular thalamic nucleus (A13;Takada 1993)] and areas A8-A10 of the ventral 
midbrain, where the most prominent source of DA in the CNS (Fig.1) is found.  
 
 
 
Figure 1. Schematic representation of dopaminergic nuclei in adult rodent brain. The scheme 
represents the disposition of main dopaminergic nuclei and their projections. A8, A9 and A10 nuclei are 
usually indicated as midbrain dopaminergic neurons with the nomenclature introduced by Dahlstrom and 
Fuxe in 1964 (Dahlström and Fuxe 1964). A8, Retrorubral field; A9,Substantia Nigra; A10, Ventral 
Tegmental Area. Image from (Björklund and Dunnett 2007) 
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The main dopaminergic nuclei in the midbrain (Mb) comprise the Retrorubral Field 
(RRF, area A8), the Substantia Nigra (SN, area A9) and the Ventral Tegmental Area 
(VTA, area A10) (Fig.2). The latter two give rise to two main circuits: the 
nigrostriatal pathway (NSp) and the mesocorticolimbic pathway (MCLp). The former 
is involved in the control of voluntary movement while the latter regulates superior 
cognitive ability such as reward, attention and emotional as well as certain aspects of 
mood control. The SN can be divided in the pars compacta, that contains DA cell 
bodies and the pars reticulata, located caudally, where are confined DA dendritic 
extensions connecting with GABAergic neuron somata.  
 
 
Figure 2. Tyrosine hydroxylase-immunostaining of mDA neurons in the adult mouse brain. (a) Anti-
TH immunostaining of the ventral tegmental area (VTA) and the substantia nigra (SN) in the adult mouse 
ventral midbrain (b). A magnification of the substantia nigra. Image from (di Porzio et al. 1990). 
 
In rodents, DA axons departing from pars compacta, reach the striatum 
(corresponding to caudate-putamen in humans), one of the principal basal nuclei, to 
form the ascending NSp. Basal nuclei are involved in motor control but do not 
connect directly with the spinal cord (Kandel et al. 2000).  
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Briefly, the striatum receives projections directly from the cortex and innervates the 
thalamus via the globus pallidus to return back to the cortex. This circuit includes a 
direct pathway and an indirect pathway, which includes the subtalamic nucleus and 
its function is to amplify activity schemes in the frontal cortex (Fig.3). At functional 
level the NSp represents the first relay of extrapyramidal tract, which controls non-
volitional muscular tone, balance, initiation and velocity of movement (Lynd-Balta 
and Haber 1994).  
 
 
Figure 3. Extrapyramidal system network. It is shown the modulatory action of the substantia nigra on 
the caudate/putamen (corresponding to the striatum in rodents). In blue are shown glutamatergic excitatory 
pathways, black arrows indicate GABA inhibitory pathways. SNr, Substantia nigra pars reticulata; SNc, 
substantia nigra pars compacta; GPi, internal globus pallidus; GPe, external globus pallidus; STN, 
subthalamic nucleus; PPN, pedunculopontine nucleus. 
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Degeneration of nigrostriatal pathway leads to an over-function of inhibitory 
GABAergic circuit from the basal ganglia with subsequent decrease of the thalamic 
excitation of the prefrontal and primary motor cortex. The consequences are 
progressive loss of muscle control, tremor, rigidity and difficulty to complete simple 
motor tasks, a condition known in humans as the Parkinson’s disease (PD; Thomas 
and Beal 2007), the syndrome described for the first time in 1817 by James Parkinson 
in his “Essay on the shaking palsy”. 
 
The VTA, organized in four primary nuclei, mainly projects to the limbic system 
(nucleus accumbens, olfactory tubercle), cortical areas (prefrontal, cingulate and 
perirhinal cortex) as well as septum, amygdala and hippocampus to form the 
mesocorticolimbic pathway (MCLp). The MCLp regulates different aspects of 
emotional behaviors, in particular mood control and reward related to natural 
pleasures like food, sex or social interactions (Wise 2004). Dysregulation of MCLp is 
linked to mood disorders (Zacharko and Anisman 1991; Martin-Soelch 2009), 
schizophrenia (Laviolette 2007), attention deficit hyperactivity disorder (ADHD; 
Ohno 2003) and drug addiction (Morales and Pickel 2012). 
These two main dopaminergic pathways in the midbrain are not completely separated 
since their projections partially overlap. Indeed previous studies has been shown that 
the dysfunction of one can bring consequences on the function of the other (Jellinger 
1991; Péron et al. 2012).   
 
1.2 Molecular aspects of the dopamine biosynthesis 
At biochemical level, DA is synthesized in the soma and in neuronal terminals from 
tyrosine. This amino acid is converted in levodopa (L-DOPA) by tyrosine 
hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis. The 
activity of this enzyme is regulated by protein kinase cyclic adenosine 
monophosphate (cAMP)-dependent (PKA). L-DOPA is then readily converted in DA 
by the ubiquitous enzyme Aromatic L-amino acid decarboxylase (AADC; Fig.4).  
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Figure 4. Dopamine biosynthesis. L-Tyrosine is converted in L-DOPA by tyrosine hydroxylase (TH) and 
in dopamine by aromatic L-amino acid decarboxylase (AADC). 
 
DA is synthesized in the synaptic terminals and promptly stored in the specific nerve-
endings organelles, called dense core vesicles, by the vesicular monoamine 
transporter (Vmat2), a 12 transmembrane domain protein. Upon the arrival of nerve 
impulse to the synaptic terminal, vesicles fuse with presynaptic membrane to release 
the DA in the synaptic cleft where it can bind 5 different postsynaptic receptors 
(DAR 1-5) to trigger a cascade of intracellular pathways that lead to the neuronal 
response. These receptors belong to the G-coupled receptor superfamily and are 
classified in two subfamilies: D1R (D1 and D5) and D2R (D2, D3 and D4).  
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The key difference between them concerns the cascade that they trigger: while D1Rs 
lead to an increase in cAMP, D2Rs are negatively coupled with the adenilate cyclase 
determining a decrease in cAMP. Both families act by modulating the cAMP/PKA 
transduction pathway to regulate the intracellular levels of Ca2+. The released DA can 
act on receptors that are distant from its release site, a modality of communication 
called paracrine transmission. DA receptors have a peculiar anatomical and cellular 
distribution. The D2 receptors, for instance, are localized on the post-synaptic 
membrane, but also on the DA neurons membranes (autoreceptors) and act by 
feedback inhibition of DA transmission, regulating DA release (Ford 2014). 
DA in the synaptic cleft is metabolized to homovanillic acid (HVA) by catechol-O-
methyl transferase (COMT) or is degraded to 3,4-dihydroxyphenylacetic acid 
(DOPAC) by the monoamine oxidase enzyme (MAO). Neurotransmission is 
terminated mainly by a process named high affinity uptake by which the released DA 
is actively captured back into the presynaptic endings through the membrane 
glycoprotein dopamine transporter (DAT). Once back in the cytoplasm, DA can be 
re-stored in vesicles or degraded by mitochondrial MAO in DOPAC. A schematic 
activity of dopaminergic transmission is showed in Fig.5. 
DAT, also known as SLC6A3, is a 12 transmembrane domain Na+-Cl- dependent 
transporter, whose importance is highlighted by the observation that DAT knock-out 
mice show spontaneous iperlocomotion due to increased persistence of DA in the 
synaptic cleft. DAT is also target of several drugs such as cocaine and amphetamine, 
indeed previous data show the insensibility of DAT-null mice to their administration 
(Thomsen et al. 2009). 
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Figure 5. Schematic representation of dopaminergic synapse. Image shows the synthesis, the storage 
and the release of dopamine with the activation of receptors and downstream intracellular cascade. DA in 
the synaptic cleft is taken up by DAT to be restored in vesicles or degraded by COMT and MAO (not 
shown). Image from (Knab and Lightfoot 2010). 
 
1.3 Molecular and transcriptional control of dopaminergic neurons 
development 
The achievement of phenotypic specificity of midbrain DA (mDA) neurons is a 
multi-step process orchestrated by cell-intrinsic factors as well as environmental cues 
that define an accurate space-time sequence. In this way, a multipotent progenitor is 
subjected to a sequential transcriptional activation that follows an accurate genetic 
program. 
The time course of development of mDA neurons can be broadly divided into 4 
stages: early midbrain patterning; induction and specification of dopaminergic 
precursors; differentiation of post-mitotic DA neurons; functional maturation of mDA 
neurons (Fig.6; Abeliovich and Hammond 2007; Perrone-Capano et al. 2008). 
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Figure 6. Midbrain dopaminergic neurons differentiation. Diagram shows the sequential activation of transcription 
factors during the time course of embryonic development. Arrows indicate possible interactions between the molecules. 
 
1.3.1 Early midbrain patterning 
Regionalization of the midbrain begins early in neural plate development (E7.5) with 
the definition of molecular borders that define the positioning of key signaling 
centers: the floor plate, present at the ventral midline, and the midbrain-hindbrain 
boundary (MHB, also known as isthmic organizer) at the caudal extreme of 
developing mesencephalon. Loss of function studies has identified a number of 
transcription factors (TFs) involved in the early patterning of midbrain. For example 
Otx2 and Gbx2, whose expression is mutually exclusive, are required for the correct 
positioning of MHB. Otx2, a member of the Otx1 family, plays a remarkable role in 
specification and regionalization of anterior structures such as forebrain and midbrain 
(Simeone et al. 2002). On the other hand, Gbx2 is expressed more posteriorly and it 
is essential for the correct development of midbrain and cerebellum.  
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Chick/quail transplantation experiments have highlighted the interplay between these 
two factors showing that the posterior limit of Otx2 marks the anterior limit of Gbx2 
expression, circumscribing the isthmus (Hidalgo-Sánchez et al. 1999). Moreover, cell 
transplantation studies shows that also Wnt8 is required for the initial subdivision of 
the neuroectoderm, including onset of posterior Gbx1 expression and establishment 
of the posterior border of Otx2 expression (Rhinn et al. 2005). Among the other 
molecules, retinoic acid (RA) is required for the proper positioning of the midbrain–
hindbrain border and is therefore indirectly needed for the correct organization of the 
midbrain (Holder and Hill 1991; Avantaggiato et al. 1996); Wnt signaling (Wnt1 and 
Wnt5A) is crucial for the establishment of the midbrain–hindbrain region and is 
involved in activating engrailed (En) genes, which are also necessary for later stages 
of mDA neuronal development (Castelo-Branco et al. 2003; Smidt and Burbach 
2007).   
A key feature of any signaling center is that it must provide a diffusible signal that 
can be received by a group of cells, which in turn may be “primed” through 
transcription of cell-specific genes. As described below, the MHB exerts its inductive 
role by secreting the fibroblast growth factor 8 (FGF8), a morphogen that drives the 
correct regionalization along the anterior-posterior axis of the developing CNS. The 
FP, conversely, secretes the lipid-modified glycoprotein Sonic hedgehog (SHH), 
which is known for its pivotal role in the specification of the different ventral 
populations along the dorso-ventral axis. 
 
1.3.2 Induction and specification of dopaminergic precursors 
Early patterning events specify a permissive region in which DA progenitors cells are 
exposed to inductive signals in a position-specific manner. In this way, gradients of 
extracellular inductors, together with cell-intrinsic responses, establish a Cartesian 
grid able to direct cells toward the specific fate depending on the cell position in the 
grid. Thus, two orders of molecular events can be recognized in the induction of DA 
phenotype: first, signaling centers secrete diffusible factors along the dorso-ventral 
12 
 
and rostro-caudal axes of the neural tube that impart positional information; 
concurrently, cell-intrinsic factors within mesencephalic progenitors progressively 
restrict cell fate choice. As pointed out above, SHH, produced by the FP, and FGF8, 
secreted by the MHB, are able to cooperate for mDA induction before E9.5 in mice 
(Hynes and Rosenthal 1999)(Fig.7).  
 
 
Figure 7. Specification of DA neurons by SHH and FGF8 gradients. Sagittal and coronal views of the 
midbrain and spinal cord of the mouse embryo showing the expression patterns of Shh, Wnt1 and Fgf8, that 
pattern the neural tube along rostro-caudal, dorso-ventral.at E9.5. FP: floor plate; IsO: isthmic organizer; 
MB: midbrain; NC: notochord; OV: otic vesicle; RP: roof plate; SC: spinal cord; ZLI: zona limitans 
intermedia. Image from (Aguila et al. 2012). 
 
Several studies show how ectopic expression of SHH and FGF8 is able to induce 
mDA neurons. Indeed DA neurons failed to develop after silencing of endogenous 
SHH with a neutralizing antibody as well as after FGF8 neutralization indicating that 
both factors are needed (Roussa and Krieglstein 2004). In vitro experiments also 
underline the importance of both factors as inductors of DA fate in neural stem cells 
line (Kim et al. 2003c) and in primary cultures (Volpicelli et al. 2004a).  
SHH, the most studied member of the Hedgehog family is initially expressed in the 
notochord and then in the floor plate.  
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The SHH protein is initially synthesized as a 45-kDa precursor protein that undergoes 
auto-proteolytic cleavage leading to an amino-terminal cleavage product of 
approximately 20 kDa (referred to as SHH-N) which is responsible for the induction 
of the floor plate at the ventral midline of the neural tube. In addition, this peptide is 
secreted by the notochord and floor plate and, as already pointed, encodes a 
ventralizing activity, thereby inducing ventral cell types (Hynes et al. 1995; Roussa 
and Krieglstein 2004). SHH acts as secreted morphogen through the binding with his 
specific receptor Patched1 (Ptc1) (Stone et al. 1996). The latter acts via the inhibition 
of the 7-transmembrane protein Smoothened (Smo) which is released after the 
binding of SHH. Smo triggers an intracellular cascade responsible for the activation 
of the zinc-finger proteins Gli (Gli1, Gli2 and Gli3), the key downstream mediators 
of the SHH response in the vertebrate neural tube (Hynes et al. 1997).  
During early steps of induction, several proteins can be detected to characterize mDA 
progenitors. One of the first molecules induced is the aldehyde dehydrogenase 2 
(Ahd2; expressed at E8.5) which is one of the major players in retinoic acid (RA) 
synthesis (Wallén et al. 1999). This observation allows to assume that RA may have a 
role not only in MHB positioning but also in neuronal fate specification.  
The above cited Otx2 also seems to have a role in early stages as Otx2-null mice fail 
to generate DA neurons (Omodei et al. 2008). Indeed, Otx2 exerts its action also by 
inhibiting the negative regulator of mDA fate Nkx2.2 (Prakash et al. 2006). Another 
function of Otx2 is to induce proneural genes such as Ngn2 and Mash1 (Ascl1) 
which are required in mitotic DA progenitors as well as in later stages (Vernay et al. 
2005). 
The LIM-homeobox gene Lmx1a, which is expressed around E9 in mice and is 
induced by SHH, plays an important role. Its overexpression is capable to ectopically 
induce mDA neurons both in vivo and in vitro (Millonig et al. 2000; Sánchez-Danés 
et al. 2012) as well as its silencing leads to a severe loss of the latter (Andersson et al. 
2006b). Notably, Lmx1a controls the expression of the homeodomain factor Msx1, a 
transcriptional repressor that inhibits expression of negative regulators of 
neurogenesis, such as the homeodomain factor Nkx6.1 (Nakatani et al. 2010). 
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Finally, this cascade induces broadly proneural factors such as Ngn2, which is 
necessary for the normal mDA generation and maturation.  
Together with Lmx1a, Lmx1b is also required in the initial steps of ventral mDA 
neurons specification (Andersson et al. 2006b). They are indeed co-expressed in 
developing midbrain and have a cooperative role in early and late phases of mDA 
neurons development by regulating proliferation, specification, and differentiation 
(Yan et al. 2011). Remarkably, Lmx1b can also induce ectopic DA neurons (Nakatani 
et al. 2010) and its action can partially overlap with Lmx1a, as showed by elegant 
experiments on the Lmx1a mutant. Indeed in this model only 46% of mDA neurons is 
lost suggesting that Lmx1b can partially compensate the loss of Lmx1a (Ono et al. 
2007). In a recent work, Deng and coworkers suggest that Lmx1b is required during 
the specification phase and influences the differentiation of several neuronal subtype 
in the midbrain, included ocular motor neurons and red nucleus neurons, while 
Lmx1a functions seem to be more restricted to the mDA fate (Deng et al. 2011).  
Strictly related with Lmx1a and b expression is the role of Foxa1 and Foxa2 
transcription factors. Indeed, a study of 2010 revealed that Lmx1a can specify mDA 
fate only within Foxa2+ mesencephalic progenitors and, conversely, the supportive 
action of Lmx1a/b through the repression of Nkx6.1 is required by Foxa2 to specify 
FP identity (Nakatani et al. 2010).  Foxa1 and Foxa2 (Foxa1/2) are members of the 
Foxa family of forkhead/winged helix transcription factors, which have diverse roles 
in regulating development, tissue homeostasis and tumorigenesis (Hannenhalli and 
Kaestner 2009). They have been strongly associated with multiple phases of mDA 
neurons development, influencing the cell fate and the expression of other 
dopaminergic-related molecules in a dosage-dependent manner (Ferri et al. 2007). 
Analysis of the double mutant for both genes has revealed a positive effect on the 
expression of neurogenic factors such as Ngn2 and Mash1 in the specification stage 
while, later in development, they are able to regulate Nurr1 and En1 in early post-
mitotic neurons and AADC and TH. In particular the binding of Foxa2 with the TH 
promoter was proven by ChIP experiments (Ferri et al. 2007; Lin et al. 2009). The 
role of Foxa2 in the specification and the maturation of mDA neurons was 
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demonstrated also in vitro by observing the increase in the DA population after its co-
overexpression with Nurr1 (Lee et al. 2010).  
Moreover, a genome-wide analysis of its targets revealed that Foxa2 is able to bind 
enhancers of floor plate genes, like Shh and Ferdl3 and promotes midbrain identity 
upregulating the expression of DA genes such as Lmx1a, Lmx1b, Msx1 and 
repressing factors involved in the specification of ventro-lateral fates like Helt, Tle4, 
Otx1 and Sox1 or also components of the SHH signaling (Metzakopian et al. 2012). 
Interestingly, mice carrying one copy of the Foxa2 gene show abnormalities in motor 
behavior in old age associated with a progressive loss of dopamine neurons, a feature 
of PD (Kittappa et al. 2007). 
Recent studies identified new players in the specification of mDA progenitors such as 
the doublesex and mab-3-related transcription factor5 (Dmrt5), which has been 
shown to regulate the expression of Foxa2, Lmx1a and Msx1 (Gennet et al. 2011), 
and the factors belonging to the Onecut family. In particular Single and double 
mutants for Onecut1 and Onecut2 showed that the extension and the distribution of 
TH+ neurons is affected in their absence, but to date their function still needs to be 
determined (Chakrabarty et al. 2012). 
 
1.3.2.1 Role of Neurogenin2 and Mash1  
The transcription factors belonging to the basic Helix-Loop-Helix (bHLH) gene 
family are known to regulate crucial developmental processes in various mammalian 
tissues. Neural bHLH transcription factors such as Neurogenin 1 (Ngn1), Ngn2, 
NeuroD, and Mash1 are expressed in both the central and the peripheral nervous 
systems during development and promote early neuronal differentiation (Kageyama 
et al. 1997; Bertrand et al. 2002). In the context of the midbrain development, Ngn2 
and Mash1 (also known as Ascl1) play a remarkable role. Both factors act forming a 
heterodimer with an ubiquitously expressed bHLH factor, E47, and activate gene 
expression by binding to a characteristic sequence called E-box 
(CANNTG)(Kageyama et al. 2005).  
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Ngn2 is a proneural gene related to the Drosophila factor atonal that is positively 
regulated by Msx1 during midbrain development (Fode et al. 1998; Andersson et al. 
2006b). Within the ventral midbrain (VM), Ngn2 expression is restricted to the 
ventricular zone (VZ), and its expression correlates both spatially and temporally 
with the generation of mDA neurons (Thompson et al. 2006). This gene has indeed 
been showed to be essential for the proper development of mDA neurons since its 
absence impairs and delays their differentiation. However the initial loss of DA 
neurons is partially recovered in later stages of development, probably due to a 
compensatory action of Mash1. Moreover, loss of function studies revealed that Ngn2 
is required for the differentiation of ventricular zone progenitors into post-mitotic DA 
precursors (Andersson et al. 2006a; Kele et al. 2006). Transplantation studies show 
how Ngn2+ cells are able to engraft into host animals where they give rise to TH+ 
neurons (Thompson et al. 2006). Interestingly the ectopic expression of Ngn2 and 
Nurr1 in neural progenitors regulates the differentiation of mDA neurons (Park et al. 
2008). 
Different studies show that also the murine homolog of achete-scute Mash1 is 
expressed in a complementary pattern with Ngn2 in the developing murine VM 
where both play an important role in regulating neurogenesis (Kele et al. 2006; Kim 
et al. 2007; Nelander et al. 2009). By generating mutations in mice in which the 
coding sequences of Mash1 and Ngn2 were swapped, researchers demonstrated that 
Mash1 and Ngn2 have divergent functions in specification of neuronal subtype 
identity, with Mash1 harboring the characteristics of an instructive determinant 
whereas Ngn2 functions behaving as a permissive factor that must act in combination 
with other factors to specify neuronal phenotypes (Parras et al. 2002). Mash1 plays a 
role at early stages of development of specific neural lineages in most regions of the 
central nervous system and of several lineages in the peripheral nervous system, in 
particular telencephalon, including ventricular zone (VZ) of the developing olfactory 
bulb (OB) and ganglionic eminences, diencephalon, midbrain, spinal cord, and retina 
(Guillemot and Joyner 1993). Indeed, loss of function and chromatin 
immunoprecipitation (ChIP) experiments showed that Mash1 regulates the expression 
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of Delta-like1 (Dll1), a strong inducer of neuronal fate (Casarosa et al. 1999; Castro 
et al. 2006; Yun et al. 2010). One of the principal features of Mash1 is to coordinate 
the program of neurogenesis by controlling the progression of neural progenitors 
through the successive phases of proliferation, cell cycle exit, and differentiation 
(Castro et al. 2011).  
Evidence that Mash1 has a role in the specification of neuronal identity has been 
obtained in different regions of the nervous system. For example, Mash1 can induce 
expression of GABAergic neuron markers such as Dlx1 and GAD67, in the cerebral 
cortex (Parras et al. 2002). It has also been reported that a cooperative or synergistic 
action with homeodomain factors specifies the subtype identity of particular neurons, 
for example Mash1 with Phox2b specifies the ventral hindbrain motor neurons 
(Dubreuil et al. 2002; Stanke et al. 2004).  
The expression of Mash1 is induced in the midbrain by Otx2 around E10 (Vernay et 
al. 2005), however its expression is also controlled by RA and by the Notch pathway 
(Jacob et al. 2013). Recent studies underline a role for Mash1 in the specification of 
DA phenotype, for example forced expression of Mash1 and Nurr1 in cortical 
progenitors caused a dramatic increase in morphological differentiation of DA cells 
(Park et al. 2006a; Park et al. 2006b; Kim et al. 2007). Elegant studies on the role of 
bHLH in the differentiation of DA lineage, have shown that Ngn2 suppresses Nurr1-
induced gene transcription in mDA neurons and that Mash1, which is expressed in 
Nurr1-positive young mDA neurons, stimulates mDA neuronal maturation 
independently from the activation of terminal differentiation markers such as Pitx3 
(Park et al. 2006a). The co-expression of Mash1 and Nurr1 produce similar results 
also in adult neural stem cells, leading to the functional differentiation of DA 
neurons, able to survive, once transplanted, into hemi-parkinsonian rats (Shim et al. 
2007). Moreover ectopic expression of Mash1 with specific factors (Brn2, Mytl1) is 
sufficient to reprogram fibroblasts into neurons (iN; Vierbuchen et al. 2010) while its 
co-expression with Lmx1a and Nurr1 reprograms fibroblasts into functional DA 
neurons (Caiazzo et al. 2011). These experiments suggest a role of Mash1 in the 
“priming” of these cells to reprogram their fate.  
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A very recent paper seems to clarify the general mechanism of action of Mash1: it 
acts as a “pioneer” factor recognizing a particular chromatin configuration, called 
trivalent state, in its target promoters; once the bHLH factor binds these regions, it 
allows the acetylation of histones and the access of other transcription factors to the 
promoter (Wapinski et al. 2013). 
 
1.3.3 Differentiation of post-mitotic mDA neurons 
As shown by 3H-thymidine incorporation studies, the transition of mDA progenitors 
from the proliferative state to post-mitotic immature neurons happens, in mice, 
around E9.5-E13.5 as they exit the cell-cycle and migrate radially from the 
ventricular surface (Bayer et al. 1995; Abeliovich and Hammond 2007). In this stage, 
radially migrating cells start to express TH, an event that occurs early (E9.5 in 
mouse) as suggested by the observation of the first TH+ cells and fibers close to the 
ventricular ependymal layer (di Porzio et al. 1990).  
Several key transcription factors, such as Engrailed (En) 1 and 2, Nurr1, Pitx3 and 
Lmx1b are involved in the development of post-mitotic mDA neurons. Here the 
expression of these factors is restricted to the early mDA neurons, suggesting that the 
factors function cell-autonomously. However, none of these transcription factors 
appear sufficient individually to instruct the mDA phenotype, suggesting a network 
model (Abeliovich and Hammond 2007). 
 
1.3.3.1 Nurr1 and Pitx3  
The Nuclear Receptor Related 1 protein Nurr1, also known as Nr4a2, is a member of 
the steroid-thyroid hormone receptor superfamily. It is expressed predominantly in 
the CNS in limbic areas and the ventral midbrain, including dopamine neurons 
(Zetterström et al. 1996). Nurr1 is currently considered an orphan nuclear receptor, 
since no ligands have been yet identified (Maruyama et al. 1998). 
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 The current hypothesis is indeed that Nurr1 acts in absence of a ligand and can 
promote signaling via its heterodimerization partner, the retinoid X receptor (RXR; 
Perlmann and Wallén-Mackenzie 2004).   
The onset of Nurr1 expression in the ventral midbrain occurs at E10.5, one day 
before the appearance of the dopaminergic marker enzyme, TH, at E11.5 (Volpicelli 
et al. 2004b) and persists in the adult brain.  
Gene inactivation studies showed that Nurr1 is essential for the later stages of mDA 
cell development, as its loss results in a specific agenesis of midbrain DA neurons. 
However, later in development, Nurr1 is expressed in a wide range of brain areas, 
where its inactivation does not seem to affect other cell types (Zetterström et al. 1996; 
Saucedo-Cardenas et al. 1998). According with these studies, Nurr1 is a direct 
regulator of a number of key DA specific genes such as TH (Kim et al. 2003b), DAT 
(Sacchetti et al. 2001), Vmat2 (Colebrooke et al. 2006) and c-Ret. The latter encodes 
for the co-receptor of the glial cell line-derived neurotrophic factor (GDNF) family 
associated to the GDNF family receptor alpha (GFRα; Wallén et al. 2001). Moreover, 
other data suggest that Nurr1 is involved in the responsiveness of mDA neurons to 
trophic factors by positively regulating brain-derived neurotrophic factor (BDNF; 
Volpicelli et al. 2007). Supporting the central role of this factor in the maturation of 
DA neurons, its overexpression is able to induce TH expression in NSC (Kim et al. 
2003c; Shim et al. 2007; Soldati et al. 2012), in ESC (Martinat et al. 2006; Abasi et 
al. 2012) and in immortalized cell lines (Castro et al. 2001).  
Defects in Nurr1 expression are associated with pathological states that affect mDA 
neurons: chronic cocaine administration downregulates Nurr1 in human and rat 
(Bannon et al. 2004; Leo et al. 2007). Notably, rare forms of familiar PD are 
associated with mutation of Nurr1 which, in turn, has been found decreased in PD 
patients (Le et al. 2003; Sleiman et al. 2009; Decressac et al. 2013). Based on these 
evidence, recent studies are attempting to exploit Nurr1 potential in transplantation 
cell therapy for PD (Wagner et al. 1999; Kim 2011; Tan et al. 2012). 
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The bicoid-related homeodomain Pituitary homeobox 3 (Pitx3) is another important 
determinant of mDA neurons identity. Its expression (E11.5 in mouse) is detectable 
in different brain areas during development but after birth is present only in mDA 
neurons where is maintained also during adulthood (Smidt et al. 1997). Data derived 
from the analysis of aphakia mutant mice (AK; which are Pitx3–/–) suggested that 
Pitx3 is specifically involved in the terminal differentiation and/or early maintenance 
of mDA neurons, as these neurons are absent in AK animals (Smidt et al. 2004; 
Smidt and Burbach 2007). Additional studies on Pitx3-null mice assessed that it is 
required during the transition of post-mitotic mesencephalic DA progenitors to TH+ 
neurons. Nevertheless there is a difference in the timing of Pitx3 expression between 
SN, where its expression precedes TH and VTA where they are expressed 
simultaneously (Maxwell et al. 2005). These data identify ontogenetically distinct 
subpopulations of dopaminergic cells within the ventral midbrain based on the 
temporal and topographical expression of Pitx3 and TH. A recent work identified a 
developmental cascade in mice in which Ahd2, a major player in RA synthesis, is 
under the transcriptional control of Pitx3. These data position Pitx3 centrally in a 
mDA developmental cascade, linking this transcription factor to RA signaling 
(Jacobs et al. 2007). Other studies underline the interplay between Pitx3 and Nurr1 
since chromatin immunoprecipitation experiments identified Vmat2 and DAT, known 
Nurr1-regulated genes, as Pitx3 targets (Hwang et al. 2009). On the other hand Pitx3 
modulates the Nurr1 transcriptional complex by decreasing the interaction with 
SMRT, which acts through HDACs to keep its target promoters in a repressed 
deacetylated state (Jacobs et al. 2009).  
A recent study, performed in our laboratory showed a direct regulation of Pitx3 
expression by Nurr1. In particular, Nurr1 can regulate Pitx3 expression through its 
binding to a non-canonical NBRE element located 220bp upstream the transcription 
initiation site on the Pitx3 promoter (Volpicelli et al. 2012). 
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1.3.3.2 En1 and En2 
Engrailed-1 (En-1) and En-2 are initially expressed during early development in a 
domain encompassing the posterior midbrain and anterior hindbrain where are 
required for the generation of MHJ (Hidalgo-Sánchez et al. 1999; Liu and Joyner 
2001). Their expression is no longer detectable until E11.5, when En1 and En2 start 
to be expressed again in ventral mDA differentiating neurons (Simon et al. 2001; 
Albéri et al. 2004). They are cell-autonomously required to prevent apoptosis of these 
neurons towards the end of embryonic development, suggesting a key role for both 
genes in the regulation of mDA neuron survival and death, a function that may 
endure also during postnatal development and maintenance (Albéri et al. 2004). 
Interestingly, the En1+/- heterozygote mice show an adult phenotype that resembles 
key pathological features of PD. Specifically, postnatal mutant mice exhibit a 
progressive degeneration of dopaminergic neurons in the SN during the first 3 month 
of their lives, leading to diminished storage and release of dopamine, motor deficits 
and a lower body weight (Sgadò et al. 2006). 
 
1.3.4 Maturation and survival of mDA neurons 
Functional maturation of newly born mDA neurons takes place as they extend axonal 
and dendritic processes that must be correctly targeted to their destinations and, at the 
same time, become capable to express molecules involved in DA synthesis, storage 
and high-affinity uptake. The activation of genes involved in DA neurotransmission 
takes place at different time in development under the control of various 
environmental cues, following the early commitment of DA neuroblasts (Perrone-
Capano and di Porzio 1996; Perrone-Capano and di Porzio 2000; Perrone-Capano et 
al. 2008). The axonal outgrowth to the target and the functional maturation are not 
separate processes as has been previously showed that interactions of presynaptic 
mDA neurons with striatal target neurons play an important role, at least in vitro, in 
promoting key aspects of DA neurotransmission (Prochiantz et al. 1979; di Porzio et 
al. 1980).  
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Studies focused on the identification of guidance factors and cues have described the 
events that unfold during mDA axonal pathfinding, synapse formation and 
stabilization. EphrinB2, involved in axonal guidance, and its receptor EphB1 can 
regulate the correct targeting of nigrostriatal neurons, with EphB1 expressed mainly 
in SN, and EphrinB2 expressed in the striatum (Yue et al. 1999). Notably, addition of 
EphrinB2 in primary mesencephalic rat cultures can lead to an upregulation of Nurr1 
transcript (Calò et al. 2005). Conversely, Nurr1 has been showed to increase 
expression of Neuropilin1, a co-receptor for the semaphorin family ligands 
(Hermanson et al. 2006). Slits and Netrins may also be involved in target recognition 
by nigrostriatal mDA neurons since in explant cultures it was clearly shown that 
guidance of mDA axons can be regulated through the Netrin1 and Slit2 pathway. 
Consistent with this notion, mDA neurons express the Slit receptors, Robo1 and 
Robo2, and the Netrin1 receptor DCC (Lin et al. 2005). Interestingly, DCC-null 
mutants show profound alterations in DA circuitry, including migration defects of 
DA progenitor cells and reduced numbers of DA cells in Mb nuclei (Xu et al. 2010). 
The importance of Slit/Robo pathway is underlined by double knock-out studies 
highlighting guidance errors during the mDA pathfinding in the ventral regions 
within the diencephalon (Dugan et al. 2011). 
Upon target innervation, mDA axons likely compete to establish functional synapses 
and survive. In particular, a wave of apoptotic mDA cell death is observed perinatally 
in rodents with an initial peak on postnatal day (P)2, and a second on P14 (Burke 
2003). Strictly connected with these events is the role of target-derived trophic 
factors, along with autocrine and paracrine signals involved in the maintenance and 
survival of these cells. The role of many trophic factors has been identified in mDA 
neuron maintenance such as the well-described GDNF (Lin et al. 1993; Beck et al. 
1995), the TGF-β (Farkas et al. 2003), BDNF (Hyman et al. 1991) and the recently 
identified conserved dopamine neurotrophic factor (CDNF; Krieglstein 2004; 
Lindholm et al. 2007). Notably, GDNF and BDNF have been show to promote the 
survival and the differentiation of mDA neurons (Hyman et al. 1991; Consales et al. 
2007) along with a positive effect on their arborization (Costantini and Isacson 2000). 
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As pointed above, BDNF is in part regulated by Nurr1, suggesting the existence of a 
Nurr1-BDNF loop protecting mDA during development and, possibly, in the 
adulthood (Volpicelli et al. 2007). According with this observation, BDNF-null mice 
show defects in the proper development of DA dendrites in the SN, although they 
have a normal asset of mDA neurons. This defect becomes evident only in the 
postnatal period and defines a role of BDNF in the phenotypic maturation (Baquet et 
al. 2005).  
In conclusion, lack or limited production of DA-associated trophic factors may play 
an important role in the pathogenesis, as well as in the potential treatment, of 
neurological diseases associated with DA neurons. 
 
1.4 Stem cell models to study mDA neurons 
In the last decades, the use of a number of cytokines and growth factors, and the 
discovery of stem cells in the embryonic and adult CNS has been exploited to 
generate DA neurons, expand DA neuron precursor populations and increase DA 
phenotype in vitro. These efforts raised the opportunity to have a simplified model in 
vitro that recapitulate, at least in part, the development of mDA neurons to analyze 
intrinsic and extrinsic cues involved in the DA fate, with the final aim to understand 
and possibly cure pathological states arising from DA system disruption. 
 
1.4.1 Stem cells 
After the bombing of Hiroshima and Nagasaki in 1945, more than 140.000 people 
died immediately but many others developed severe leukemia and total loss of the 
bone marrow due to massive radiation exposition (Jacobson et al. 1951). Just a few 
years later hematologists discovered a population of cells in the bone marrow capable 
of replacing all the blood cells (Nowell et al. 1956; Ford et al. 1956). These cells 
were later identified as stem cells.  
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Stem cells are undifferentiated cells that can be toti-, pluri- or multipotent. During the 
embryonic development, they are the founder cells of every tissue, organ and cell in 
the body of animals and plants, while in the adulthood they constitute a sort of repair 
system of the body and can divide without limit to replenish other cells as long as the 
animal or plant is alive. Key features that define a stem cell are the ability to self- 
renew through cell division (asymmetric division) and the competence to generate 
specialized cell types through differentiation. The asymmetric division is a distinctive 
biological characteristic, which distinguishes the stem cells (or multipotent 
progenitors) from all other cell types where the mitotic division is symmetrical 
(Bellenchi et al. 2012). As they differentiate to give rise to different types of cells in 
various tissues, their potential becomes more restricted and, at the same time, their 
number decreases. Nevertheless, in the adult various organs retain a stem cell 
compartment, located in a specific microenvironment, called niche, which regulates 
their behavior (Doetsch 2003a). Generally, adult stem cells are uni- or multipotent as 
they give rise only to cell lineages required by the specific tissues containing their 
niche. Here, stem cells may be present in different proliferative state depending on 
the organ in which they are present. For example, niches show active proliferation in 
tissues that require a high cell turnover, such as the blood, the epidermis, the 
intestinal epithelium and male gonads while in tissues where cell loss is limited, such 
as the liver, the teeth and the brain, the stem cells are present in a quiescent or low 
proliferation state. However, in these tissues proliferation can be activated by 
physiological and pathological stimuli (Bellenchi et al. 2012).  
Very recent studies opened the interesting perspective of generating stem cells from 
adult somatic cells. The so called induced pluripotent stem cells (iPSC) are obtained 
by overexpressing into skin fibroblasts a set of transcription factors able to 
“reprogram” the cell to a pluripotent state (Takahashi and Yamanaka 2006; 
Yamanaka and Blau 2010). On the general wave of enthusiasm generated by this 
discovery, several works were produced to directly convert fibroblast into neurons 
(iN; Vierbuchen et al. 2010) and finally into functional DA neurons (iDA; Caiazzo et 
al. 2011).  
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In contrast, several problems are associated with iPSC generation such as genomic 
instability and chromosomal aberrations, raising interrogatives about their therapeutic 
use (Hussein et al. 2011; Pera 2011). Nevertheless, they constitute an invaluable tool 
to modelling several pathologies such as schizophrenia (Brennand et al. 2011), PD 
(Byers et al. 2012), Huntington’s disease (Camnasio et al. 2012) and Alzheimer’s 
disease (Yagi et al. 2011). 
 
1.4.2 Neural stem cells 
Neural stem cells (NSCs) are defined by their ability to proliferate, self-renew and to 
give rise to all the cell lineages of the brain, namely neurons, astrocytes and 
oligodendrocytes. These features are defined by the competence of NSC to undergo 
symmetric or asymmetric divisions depending on developmental stage. During early 
neurogenesis of the embryonic mouse brain, most NSC divisions are symmetric to 
expand the NSC pool and to establish a stable niche compartment. With the 
progression of neurogenesis, an increasing fraction of asymmetric divisions gives rise 
to progenitor cells, which migrate to their final positions (Götz and Huttner 2005; De 
Filippis and Binda 2012). Regarding the embryonic development, the term “neural 
stem cell” can identify a number of neuronal precursors, capable to originate both 
neurons and glia, with different features. First, in the embryonic ventricular zone 
neuroepithelial stem cells generate most of the neurons and glia in the brain, already 
at the start of neurogenesis these cells are gradually replaced by radial glia, as shown 
by fluorescent-activated cell sorting experiments (Malatesta et al. 2000). Radial glial 
cells show several astroglial properties and express markers known to the glial 
lineage, such as GFAP, however recent evidences raised the intriguing possibility that 
radial glia may also be stem cells/progenitors during embryonic development 
(Alvarez-Buylla et al. 2001). The stem cell/progenitor function of radial glia and 
astrocytes strongly suggests that stem cells are found within the 
neuroepithelial→radial glia→astrocyte lineage (Doetsch 2003b).  
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Also adult NSC are thought, in turn, to retain a glial identity, as showed by literature 
data showing that cells with characteristics and markers of embryonic radial glia are 
found only in the adult SVZ and SGZ (Doetsch et al. 1999; Kriegstein and Alvarez-
Buylla 2009). In adult mammals, NSCs are mainly confined in the “neurogenic” 
areas, that are the subgranular zone (SGZ) in the dentate gyrus of the hippocampus 
and the subventricular zone (SVZ) of the lateral ventricles (Gage 2000). These areas 
are the niches that regulate NSC self-renewal, activation and differentiation (Doetsch 
2003a). In the niches astrocytes serve as both neural stem cells and niche cell and 
"embryonic" molecular morphogens and signals persist in these niches and play 
critical roles for adult neurogenesis (Alvarez-Buylla and Lim 2004). 
Many factors can regulate NSC homeostasis, such as environmental signals from the 
niche as well as cell-cell interactions and intrinsic factors involved in the regulation 
of the balance between multipotent/proliferative state and differentiation. Astrocytes 
provide rapid propagation of signaling within the stem cell niche. Furthermore, 
astrocytes themselves secrete factors that support neurogenesis in vitro (Lim and 
Alvarez-Buylla 1999). Also Noggin, produced by ependymal cells in the niche, is 
responsible to maintain the neurogenic potential of NSC by antagonizing bone 
morphogenic proteins (BMP) signaling, which instead promotes differentiation (Lim 
et al. 2000). On the other hand, in vivo and in vitro experiments have provided a 
strong role for EGF signaling in the induction and maintenance of the multipotency 
(Doetsch et al. 2002). Interestingly, oxygen plays a critical role in regulating the 
growth and differentiation state of NSC. In vitro and in vivo various studies show that 
low O2 increases the hypoxia-inducible factor 1alpha (HIF-1α), which promotes self-
renewal and inhibits NSC differentiation or apoptosis while increased O2 tension has 
opposite effects (Panchision 2009; De Filippis and Delia 2011).  
Given their unique features, NSCs are considered to be the best candidate for 
replacement therapy in the treatment of a number of nervous system disorders. 
Indeed, transplantation of stem cells or their derivatives in animal models of 
neurodegenerative diseases can improve function by replacing the lost neurons and 
glial cells and by mediating remyelination, trophic actions, and modulation of 
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inflammation (Lindvall and Kokaia 2010). For example, transplantation of human 
neural progenitor cells genetically modified to secrete GDNF into the striatum and 
substantia nigra protected injured DA neurons (Behrstock et al. 2006). Similarly, 
NSC injected into substantia nigra and striatum of nonhuman primates mediated 
recovery, possibly by giving rise to a small number of cells with DA neuron 
phenotype (Redmond et al. 2007). Cell transplantation studies has given promising 
results also for amyotrophic lateral sclerosis (ALS; Xu et al. 2006; Xu et al. 2009), 
spinal cord injury (Cummings et al. 2005) and stroke (Kelly et al. 2004; Bacigaluppi 
et al. 2008; Bacigaluppi et al. 2009). However in many models of neurodegenerative 
diseases, on the long-term the “affected” brain environment may damage healthy 
engrafted neurons resulting in a exacerbation of the pathology, as showed by 
literature data (Li et al. 2008; Brundin et al. 2008; Desplats et al. 2009). 
Strikingly, recent evidence has carved out a role for NSCs as immunomodulators. 
Indeed they are shown to be able to promote neuroprotection by maintaining 
undifferentiated features and exerting unexpected immune-like functions (Pluchino et 
al. 2005). Moreover, toll-like receptors (TLR), tightly associated with inflammatory 
response, are expressed by NSCs controlling their proliferation and differentiation 
properties. This suggests that TLR activation on NSCs regulates neurogenesis in 
response to injury and inflammation (Martino and Pluchino 2007). Finally, in 
experimental autoimmune encephalomyelitis (EAE) models, transplanted NSC 
control immune system activation through a bystander effect (Pluchino et al. 2009). 
Pathological conditions can be associated to alterations in NSC homeostasis. Recent 
evidence suggest that the perturbation of molecular mechanisms that normally 
regulate the balance between proliferation and differentiation in NSC can be, at least 
in part, associated with the progression of malignant brain tumors (Verginelli et al. 
2013; Modrek et al. 2014). The view that tumor stem cells underpin the development 
and/or maintenance of brain cancer has been confirmed by their identification in 
tumors of the central nervous system (Ignatova et al. 2002; Singh et al. 2003).  
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Other studies indicate the possibility that mutations of the leucine-rich repeat kinase 
2 (LRRK2), common in sporadic forms of PD, could be associated with 
dysfunctional NSC pools and might contribute to the hippocampal and SVZ-related 
age-dependent non-motor symptoms, including depression, anxiety and hyposmia 
(Liu et al. 2012).   
 
1.4.3 Neurogenesis in the adult 
At the begin of ‘900 the father of neurobiology Santiago Ramon y Cajal wrote: 
“Once development was ended, the fonts of growth and regeneration of the axons 
and dendrites dried up irrevocably”, the so called central dogma of neurobiology that 
strengthened the idea that new neurons could not be formed and integrate in an adult 
brain (Colucci-D’Amato et al. 2006). The relative recent discovery of NSC in the 
brain along with the latest experiments on their function put an end to debate opening 
a totally new field of interests about neurogenesis in the adult, and its consequences. 
The first evidence of neurogenesis in the adult brain goes back to the 1960s when 
Joseph Altman showed that cells in the dentate gyrus of the hippocampus could 
incorporate radioactive thymidine (Altman 1962). Later, Kaplan and Hinds, using the 
electron microscopy coupled with autoradiography, demonstrated that the thymidine-
labeled cells were neurons (Kaplan and Hinds 1977). In the 1980s, Nottebohm and 
his colleagues published a series of elegant studies showing that a substantial number 
of new neurons are produced in the song system of adult birds (Paton and Nottebohm 
1984; Nottebohm 1989). However, the first evidence of a cell with “stemness” 
features in the adult brain came, for the first time, in 1992 when Reynolds and Weiss 
employed a serum‐free culture system known as the neurosphere assay (NSA), to 
isolate and expand the putative stem cells from the adult brain, wherein most of the 
primary differentiated CNS cells harvested would not be able to survive (Reynolds 
and Weiss 1992).  
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As pointed out above, in adult mammals NSCs are confined to SGZ generating 
granular neurons, and the SVZ where new neuroblasts are continuously produced and 
migrate through the rostral migratory stream (RMS) to the olfactory bulb (Fig.8; 
Gage 2000; Curtis et al. 2007). 
 
 
Figure 8. Neurogenic areas in the adult brain.  The diagram represents a sagittal section of mouse brain 
showing the two canonical regions of adult neurogenesis: the subgranular zone (SGZ) of the dentate gyrus 
(DG, violet) in the hippocampal formation (HP), and the subventricular zone (SVZ) of the lateral ventricle 
(LV). The neural progenitors generated in SVZ will reach the olfactory bulbs (OB) through the rostral 
migratory stream (RMS, red). 
 
In adult birds the new cells are generated from lateral ventricles and migrate to their 
final destinations, where they attained morphological and ultrastructural 
characteristics of neurons, extended axons into appropriate target regions, received 
synaptic input and were activated by auditory stimuli (Alvarez-Buylla et al. 1988). 
The newborn neurons in the hippocampus have enhanced synaptic plasticity for a 
limited time after their differentiation which is critical for their role in mediating 
pattern separation in memory formation and cognition in rodents (Ge et al. 2007; 
Clelland et al. 2009; Deng et al. 2009).  
A still opened question is whether neurogenesis is constrained only in the two 
canonical zones, SVZ and SGZ, or could occur also in other brain areas (Gould 
2007). A seminal work by Gould and collaborators demonstrated that neuroblasts 
generated in the SVZ migrate in three different regions of the neocortex in adult 
macaque (Gould et al. 1999) while other brain areas are subjected to a “local” 
neurogenic potential following injuries or lesions, such as the rat visual cortex (Sirko 
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et al. 2009), the layer VI of the cortex (Magavi et al. 2000) and also the spinal cord 
meninges that harbor nestin- and doublecortin-positive cells, which are activated after 
injury and migrate into the spinal cord forming glial scars in vivo and can give rise to 
neurons and oligodendrocytes in vitro (Decimo et al. 2011). Strikingly, recent works 
provided evidences for neurogenesis in the adult mammalian substantia nigra where 
newly generated dopaminergic projection neurons derive from a population of 
actively dividing progenitor cells lining the cerebroventricular system in the midbrain 
(Lie et al. 2002). Although the number of neurons generated is orders of magnitude 
lower than in the hippocampus or the olfactory bulb, the estimated turnover rate 
implies, provided the rate is constant, that the entire population of SN neurons could 
be replaced within the life span of the mouse (Zhao et al. 2003).  
What about humans? One of the first evidences of neurogenesis in the adult human 
hippocampus was provided by Eriksson et al. by studying bromodeoxyuridine (BrdU) 
incorporation in post-mortem human brains (Eriksson et al. 1998). Subsequent studies 
estimated the extent of adult neurogenesis in humans, quantifying the number of cells 
expressing the neuronal precursor marker doublecortin (DCX) in the subventricular 
zone, which gives rise to olfactory bulb neurons, and in the dentate gyrus of the 
hippocampus. These two regions contain a large number of neuroblasts shortly after 
birth that decreases sharply during the first postnatal year and then declines more 
moderately through childhood and adult life (Knoth et al. 2010; Sanai et al. 2011; 
Wang et al. 2011). By using an elegant cell birth dating technique, which consist in 
measuring the concentration of nuclear bomb test-derived 14C in genomic DNA 
(Spalding et al. 2005), Spalding and co-workers recently demonstrated the generation 
of hippocampal cells in human brains estimating that 700 new neurons are added in 
each hippocampus per day, corresponding to an annual turnover of 1.75% of the 
neurons within the renewing fraction, with a modest decline during aging (Spalding 
et al. 2013). Using a similar approach, Ernst et al. were able to show that in adult 
humans new neurons, generated is the lateral ventricle wall of the brain, integrate in 
the striatum and that these are preferentially depleted in patients with Huntington’s 
disease (Ernst et al. 2014). 
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It is now well established that adult neurogenesis can be increased by external 
stimuli, such as enriched environment (Kempermann et al. 1997), voluntary physical 
exercise (van Praag et al. 1999) as well as by dietary modulation (Park and Lee 
2011). On the other hand, stress and depression can affect the generation of new 
neurons (Gould et al. 1998; Mirescu and Gould 2006; Castrén and Rantamäki 2010) 
while antidepressant treatment seems to have a positive effect (Malberg et al. 2000; 
Santarelli et al. 2003; Wang et al. 2008). 
 
1.4.4 In vitro differentiation strategies to obtain DA neurons 
Embryonic stem cells (ESC) and NSC offer a potentially simplified in vitro model 
system for the analysis of mDA maturation relative to the intact mammalian CNS. 
Furthermore, stem-cell-derived DA neurons may be of therapeutic benefit in cell 
replacement strategies for neurodegenerative disorders because of their potentially 
limitless supply. A number of studies have shown that ESC and NSC can generate 
cells with a mDA phenotype, and that the developmental program in vitro appears to 
recapitulate the temporal course of normal mDA maturation (Kim et al. 2003c; 
Barberi et al. 2003; Andersson et al. 2006b; Martinat et al. 2006; Young et al. 2010; 
Meyer et al. 2012).  
The first in vitro studies on DA neurons differentiation and maturation were based on 
the reconstruction of the brain environment in which they develop. For instance, 
culturing mDA progenitors from embryonic brains in presence of their striatal target 
can induce a functional maturation of these cells (Prochiantz et al. 1979; di Porzio et 
al. 1980). In the same way, other protocols are based on the use of astrocyte 
conditioned media that could mediate a trophic and pro-survival action on 
differentiating progenitors as well as the use of striatal extracts that can enhance DA 
neurons maturation mediated by the presence of BDNF and GDNF (Daadi and Weiss 
1999; Zhou et al. 2000). 
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Although all available evidence demonstrates that ESC have a greater capacity to 
produce dopaminergic neurons than NSC or other types of lineage-specific stem cells 
(Lee et al. 2000; Cho et al. 2008), there are some advantages in deriving DA neurons 
from NSC. Firstly, as a cell type already restricted to the neural lineage, NSC do not 
generate teratoma following transplantation. Secondly, NSC can be derived from 
fetal and adult brains, thus one could envisage the potential use of a patient's own 
NSC in cell therapy to avoid immune rejection (Gale and Li 2008). Beside the above 
cited neurosphere assay, several methods were developed to isolate and maintain 
neural stem/progenitors cells in vitro (Colucci-D’Amato et al. 1999; Volpicelli et al. 
2004a; Conti et al. 2005; Pollard et al. 2006; Hook et al. 2011). One of the issues 
associated with these protocols is the maintenance of the self-renewal state by using 
several factors (Shi et al. 2008) to propagate a cell population that has to be as 
homogeneous as possible. For instance, it has been shown that TH-positive neurons 
were generated from bFGF-expanded NSCs, but only in early passages; these results 
suggest that primary TH-positive neurons may be carried over at the time of 
dissection or the expanded cells may not be NSC but constantly differentiating 
progenitor cells (Studer et al. 1998). 
Basically, there are two way to differentiate NSC in vitro: by adding soluble extrinsic 
factors to the culture media or by ectopically introduce into NSC essential intrinsic 
factors such as key transcription factors.  
One of the hallmarks of many in vitro differentiation protocols is the recapitulation of 
the principal stages of development: induction and specification phase, in which are 
principally used morphogens and mitogens, followed by a differentiation stage in 
which are used molecules and factors that promote DA differentiation and survival. 
Among inductors, the action of morphogens SHH and FGF8 was shown to be 
efficient to induce DA fate (Hynes et al. 1995; Volpicelli et al. 2004a; Volpicelli et 
al. 2004b). SHH signaling play a central role both in the proliferative phase of NSC 
and in the responsiveness of the latter to DA-inducing factors (Kim et al. 2003c; 
Martínez et al. 2013).  
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Wnt and TGF-β were also shown to have a strong role in the induction and 
specification of DA cells in vitro (Farkas et al. 2003; Roussa and Krieglstein 2004; 
Roussa et al. 2008; Rössler et al. 2010). 
The other task of the differentiation protocols is to ensure the correct maturation and 
survival of DA cells by using differentiation and survival factors, such as BDNF 
(Engele 1998), GDNF (Consales et al. 2007), ascorbic acid (Volpicelli et al. 2004a), 
and cyclic adenosine monophosphate (cAMP; Michel and Agid 1996).  
Other environmental conditions are shown to enhance DA differentiation, for 
instance low oxygen during bFGF-mediated expansion resulted in a significant 
increase in TH+ dopaminergic neurons as compared to high oxygen tension (Jensen et 
al. 2011). In the same way, depolarization induced by KCl treatment can increase DA 
differentiation (Volpicelli et al. 2007). In particular, recent works have shown that 
this treatment promotes DA neuron differentiation by opening chromatin structures 
surrounding DA related genes and by inhibiting the binding of co-repressors (He et 
al. 2011). Other studies take in account the action of molecules that are known to 
trigger pro-dopaminergic pathways, for instance it has been shown that the 
overexpression of the transmembrane molecule B-cell lymphoma-extra-large (Bcl-
XL) not only exerts its known anti-apoptotic effect but also induces proneural and 
DA-related transcription factors, resulting in a high yield of DA neurons with the a 
phenotype resembling those of SN pars compacta (Park et al. 2006b; Courtois et al. 
2010). 
A similar approach may be taken into account to program dopaminergic competent 
NSC by exploiting transcription factors known to act in this specific neuronal lineage. 
Interestingly a great number of studies point on the above cited TF Nurr1, whose 
overexpression has been shown to efficiently induce DA neurons (Wagner et al. 
1999; Kim et al. 2003a; Kim et al. 2003c). However, although Nurr1-induced cells 
are positive to DA markers, they show an immature phenotype (Park et al. 2006b; 
Park et al. 2012).  
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For this reason, other experiments suggest the co-expression of other TF such as 
Foxa2 (Lee et al. 2010) and Brn4 (Tan et al. 2012), while a number of articles 
highlight a possible cooperative mechanism with bHLH factors (Park et al. 2006a; 
Park et al. 2006b; Kim et al. 2007; Park et al. 2008). Other studies will clarify the 
nature and the mechanisms of these cooperation. 
 
1.5 Aim of the project 
As described in the preceding part, the development of dopaminergic neurons, at 
molecular level, is a highly concerted process in which extracellular signals and 
sequential activation of specific transcription factors (TFs) are integrated to define 
their physiological, morphological, and molecular phenotype.  
A crucial task is to unveil the network of interactions and the hierarchy of molecular 
events underlying the acquisition of the dopaminergic function.  
Previous data in the literature suggest that, among others, two TFs could cooperate to 
determine DA neurons identity: Nurr1 and Mash1.  
Nurr1 is an orphan nuclear receptor member of the steroid-thyroid hormone receptor 
superfamily expressed in mDA post-mitotic progenitors starting from E10.5 and 
persists in the adult brain. Nurr1 is essential for mDA neurons development as its loss 
results in the agenesis of mDA neurons (Zetterström et al. 1996; Saucedo-Cardenas et 
al. 1998). Indeed Nurr1 is a direct regulator of a number of key DA specific genes 
such as TH (Kim et al. 2003b), DAT (Sacchetti et al. 2001), VMAT2 (Colebrooke et 
al. 2006).  
Mash1 (Ascl1) is a bHLH transcription factor known as proneural. It is essential for 
neuronal specification in early developmental stages (Kageyama et al. 1997; Bertrand 
et al. 2002). It is expressed from early stages of embryonic development in different 
brain areas including midbrain where is induced by Otx2 at around E10 and last 
during the early post-mitotic phase (Vernay et al. 2005), however a role for Mash1 
during later phases has not yet been described. Previous studies suggest that Mash1 
might have a broad role in the subtype specification of different neuronal populations 
(Kim et al. 2008).  
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Interestingly, in developing midbrain, Mash1 expression overlaps with that of Nurr1 
in a subset of Ahd2+ cells (Kele et al. 2006; Park et al. 2006a; Nelander et al. 2009). 
Similar studies underline the importance of Mash1 and Nurr1 in the reprogramming 
of somatic cells into dopaminergic neurons (Caiazzo et al. 2011).  
I hypothesized that these two TFs may cooperate during the dopaminergic lineage 
commitment by controlling the switch from the specification phase to the post-mitotic 
differentiation fate, in order to trigger the molecular events leading to the correct 
development of fully differentiated midbrain DA neurons.  
The aim of this project is thus to push Neural Stem Cells, obtained from embryonic 
brains with the neurosphere assay, to differentiate towards dopaminergic fate through 
the overexpression of Mash1 and Nurr1. The role of these TFs has been studied by 
characterizing differentiated cells from a morphological and functional point of view 
through the analysis of the DA markers TH, DAT, VMAT2 and Pitx3. In parallel I 
clarified the transcriptional regulation of genes of interest in the DA lineage, upon 
Mash1 and Nurr1 overexpression, using molecular biology approaches.  
Altogether these data will shed light on the molecular and cellular events underlying 
the differentiation of DA neurons to enhance their generation in vitro and in vivo for 
possible future therapeutic purposes. 
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2. MATERIAL AND METHODS 
 
2.1 Cell cultures 
Materials for tissue culture, like multiwell plates, serological pipettes or pipette tips, 
were purchased from Corning, BD Biosciences or Nunc. All steps were carried out 
inside a laminar flow sterile hood (Jupiter) to avoid contamination. All the equipment 
was sprayed with Ethanol (70%) before use. Cells were incubated at 37°C with 5% 
CO2 in a humidified incubator (Thermo Forma). Dissections were performed inside a 
horizontal flow hood (Hermes II).  
 
2.1.1 Animals and dissections 
Timed pregnant wild type or TH-GPF C57 BL-6 mice were sacrificed in accordance 
with Society for Neuroscience guidelines and Italian law. The embryonic age (E) was 
determined by considering the day of insemination (as confirmed by vaginal plug) as 
day E0. Embryos from day 12.5 (El2.5) of gestation were quickly removed and 
placed in phosphate buffered saline (PBS), without calcium and magnesium, and 
supplemented with 33mM glucose. The ventral midbrain or cortex was carefully 
dissected under a stereoscope in sterile conditions and processed for cell cultures. 
Tissues were pooled and triturated with a chemical and mechanical dissociation.  
 
2.1.2 Neurospheres cultures  
Single cells were obtained from embryonic cortex and midbrain as previously 
described (di Porzio et al. 1980). Briefly, the tissues were transferred into a 15 mL 
tube and treated for 30 min at 37°C with a solution containing papain (Worthington, 
20 U/mL) dissolved in EBSS (Invitrogen) with the addition of cysteine (Sigma-
Aldrich; 1 mM) and EDTA (Sigma-Aldrich; 1 mM) and 0,01% pancreatic DNAse. 
After addition of 1 mg/mL of bovine serum albumin (Sigma-Aldritch) and 1 mg/mL 
ovomucoid (Sigma-Aldritch) and mechanical dissociation with a sterile pipette, the 
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cell suspension was centrifuged 5 min at 500 rpm, resuspendend in plating medium 
and counted. For the viable count, cell suspension was diluted 1:10 with 0,1% trypan 
blue and loaded into a Burker’s counting chamber slide. Cell concentration was 
determined on the basis of the total cell count, the dilution factor and the trypan blue 
exclusion.  
Dissociated cell were plated in suspension at a density of 3x104/mL in 75cm2 tissue 
culture flasks (Corning). Cells were grown in DMEM/F12 with Glutamax™ 
(Invitrogen) supplemented with N2 (Invitrogen), B27 without retinoic acid 
(Invitrogen), 100 U/ml Streptomycin, 100 μg/ml Penicillin (Sigma), bFGF (20ng/mL; 
Sigma) and EGF (20ng/mL; Sigma). After 3 days in culture (days in vitro, DIV) 
clonal aggregates, called neurospheres, were observed  and after 5 DIV, as they reach 
≈150µm diameter, where collected in a 15 mL tube, sedimented for 5 min at 200g 
and resuspended in 1 mL of TrypLE reagent (Life Technologies). Cells were 
incubated at 37°C for 4 min, mechanically dissociated using a wetted P1000 pipette 
tip, diluted 1:6 in DMEM/F12 and centrifuged for 5 min at 500g. Subsequently, the 
cells were resuspended in plating medium and counted as described above. For each 
passage, counted cells were plated at the same initial density. 
 
2.1.3 Neurospheres differentiation into neurons and astrocytes 
For the demonstration of the multipotency, cells were differentiated as previously 
described (Rietze and Reynolds 2006). Briefly, neurospheres were harvested, 
dissociated and counted as described above, and then single cells are plated at a 
density of 2,5x105 cells/cm2 on glass coverslips for immunostaining analyses or 12-
well plate for RNA extraction. Both coverslips and multiwells were previously coated 
with 15μg /ml poly-D-lysine (Sigma) for 1 hour at 37°C and washed three times with 
sterile H2O. Cells were allowed to differentiate in DMEM/F12 supplemented with 
1% FBS (Euroclone), 100 U/ml Streptomycin and 100 μg/ml Penicillin (Sigma). 
After 3 DIV half of the medium was replaced with fresh medium and at 6 DIV cells 
were fixed for immunostaining or harvested for RNA extraction.  
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To obtain individual cultures of neurons or astrocytes a different protocol were used 
according with Johe et al. (Johe et al. 1996). Neurospheres were collected, 
dissociated and plated on coated coverslips or 12-well plates at a density of 6x104 
cells/cm2. Cells were expanded in DMEM/F12 supplemented with N2 (Invitrogen), 
B27 (Invitrogen), 100 U/ml Streptomycin, 100 μg/ml Penicillin (Sigma) and bFGF 
(20ng/mL; Sigma-Aldritch) for 24-48h. Upon bFGF withdrawal, cells were allowed 
to differentiate for 6 days in presence of 10 ng/mL PDGF-BB (Sigma-Aldritch) to 
enhance neuronal differentiation or 10 ng/mL CNTF (Sigma-Aldritch) to push 
astroglial fate. Half of the medium was replaced every 3 DIV then cells were fixed 
for immunostaining analyses or processed for RNA extraction.  
 
2.1.4 Generation of dopaminergic precursors from neurospheres 
To properly differentiate neurosphere-derived cells, I adapted the protocol used in our 
lab for the expanded cultures (Volpicelli et al. 2004b). In brief, neurospheres, derived 
from cortex and midbrain, were collected, dissociated at single cells and counted as 
described above. Cells were plated at a density of 3x104/cm2 onto poly-D-lysine 
coated coverslips or multiwells. The protocol consists of a proliferative/inductive 
phase and a differentiation stage. For the first phase cells were allowed to proliferate 
under inductive conditions for 6 DIV in DMEM/F12 supplemented with N2 
(Invitrogen), B27 without retinoic acid (Invitrogen), 100 U/ml Streptomycin, 100 
μg/ml Penicillin (Sigma), bFGF (20 ng/mL; Sigma-Aldritch), N-terminal-SHH 
(50ng/ml) and FGF8 (10 ng/ml; Sigma). At DIV 3 half of the medium was replaced 
and inducible lentiviruses (see below) carrying the sequences for Mash1, Nurr1 or 
GFP (negative control) were added at respective dilutions of 1:10, 1:15 and 1:10. At 
DIV 6, for the switch to the differentiation phase, proliferative medium was replaced 
with DMEM/F12 supplemented with N2 (Invitrogen), B27 with retinoic acid 
(Invitrogen), 100 U/ml Streptomycin, 100 μg/ml Penicillin (Sigma), Ascorbic acid 
(200 μM; Sigma), 1mM dibutyryl cyclic adenosine 3’, 5’-monophosphate (cAMP; 
Sigma), GDNF (10 ng/mL; Sigma).  
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The expression of transgenes was induced by the addition of Doxycycline (DOX) 
(4μg/ml; Clontech) to the medium. At DIV 12 cells were fixed or collected for further 
analyses. 
 
2.1.5 A1 cells cultures and differentiation 
Mes-c-myc-A1 (A1) cells were generated from a single clone of immortalized cells, 
by means of c-myc infection, from E11 mouse embryonic mesencephalon (Colucci-
D’Amato et al. 1999). A1 were cultured in minimal essential medium MEM/F12 
(Invitrogen) supplemented with 10% FBS (Euro clone) and 100 U/ml Streptomycin, 
100 μg/ml Penicillin (Sigma). Before seeding the cells plate were previously coated 
with 15μg /ml poly-D-lysine (Sigma) for 1 hour at 37°C and washed three times with 
sterile H2O.  
For Mash1 and Nurr1 over-expressing lentiviruses infections, cells were plated at 
5000/cm2 density and infected 24 hours later. At the same time, insert transcription 
was induced by the addition of Doxycycline (DOX) (4 μg/ml; Clontech) to the 
culture medium. 
To differentiate A1 cells, 48 hours after the infection, serum containing medium was 
replaced by MEM/F12 supplemented with N2 (Invitrogen), 1mM dibutyryl cyclic 
adenosine 3’, 5’-monophosphate (cAMP; Sigma), N-terminal-SHH (50ng/ml), FGF8 
(10 ng/ml; Sigma) and Ascorbic acid (200 μM Sigma). Medium was replaced once 
every three days. Cells were harvested after 6 days. 
 
2.1.6 HeLa cells cultures 
HeLa are an immortalized epithelial human cell line derived from cervical cancer 
cells (Scherer et al. 1953) . HeLa were maintained at 37°C with 5% CO2 in a 
humidified incubator, in DMEM (Invitrogen) with 10% fetal bovine serum (FBS; 
Euroclone) and 100 U/ml Streptomycin (Sigma) and 100 μg/ml Penicillin (Sigma). 
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2.1.7 HEK 293T cells cultures 
Human embryonic kidney 293T (HEK293T) cells were generated from human 
embryonic kidney cells obtained from a single apparently healthy fetus legally 
aborted. In the early 70s, these cells were genetically transformed with Adenovirus 5 
DNA to obtain a stable cell line (Graham et al. 1977). 
Cells were maintained at 37°C with 5% CO2 in a humidified incubator, in DMEM 
(Invitrogen) with 10% fetal bovine serum (FBS; Euroclone) and 100 U/mL 
Streptomycin (Sigma), 100 μg/mL Penicillin (Sigma) and 25mM Hepes (Invitrogen). 
 
2.2 Immunocytochemistry 
After medium removal, cells were washed twice with PBS and then fixed with 4% 
paraformaldehyde (PFA; Sigma) in PBS at RT for 30min. Cells were permeabilized 
for 15 min with PBS-0.1%Triton-X-100 (Sigma). Later, fixed cells were incubated in 
a blocking solution with 5% BSA (Sigma) and 10% of normal goat serum (NGS;) in 
PBS at RT for 1h and then with the primary antibody (the dilution was specific for 
each antibody), usually overnight at 4°C or 2h at RT. Subsequently, cells were 
washed three times in PBST, incubated 45 min-1h at RT with the fluorescence-
labelled secondary antibody (1:400; Alexa Fluor®, Invitrogen). In the end, cells were 
washed again in PBS and counterstained with DAPI (1:1000; Invitrogen). A complete 
list of the used primary antibodies is reported in Table 1. 
 
Table 1. List of used primary antibodies for immunocytochemical stainings 
Antigen Manufacturer Host Dilution 
TH Millipore Rabbit 1:400 
TH Chemicon Mouse 1:400 
Mash1 BD Pharmingen Mouse 1:400 
Flag (M2) Sigma-Aldritch Mouse 1:1000 
Tuj1 Covance Mouse 1:500 
GFAP Sigma-Aldritch Rabbit 1:400 
Nestin Chemicon Mouse 1:1000 
Sox2 Millipore Rabbit 1:700 
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2.2.1 Microscopy and quantitative analyses 
Images were acquired using a Leica DMI 6000 inverted microscope. In order to 
compare pictures from the same set of experiments, images were taken keeping the 
same settings on the acquisition software (Leica Application Suite AF). For cell 
counts, the number of positively stained cells was quantified by using a custom 
macro in the ImageJ software. Briefly, 8-bit images from each channel were 
generated and converted in a binary image, and then the area of the smallest cell was 
measured. Cells were counted with the “analyze particles” tool by setting the standard 
circularity and the minimal size value obtained from the previous measure. For 
neuronal cells counting, a similar approach was used but, to overcome the generation 
of counting artefacts due to the peculiar shape of the cells, an image resulting from 
the comparison between the analyzed channel and the DAPI channel was generated 
with the “AND” operator in the Image calculator tool. 
 
2.3 Molecular biology methods 
 
2.3.1 Lentiviral vectors construction and transduction  
Last generation lentiviruses have been engineered in order to contain less than 10% 
of the original viral genome. They express only sequences needed for reverse 
transcription and integration of the gene expression cassette into the host genome. To 
further increase the security level, these genes are expressed on three different vectors 
in a way to minimize the risk for a casual recombination event able to restore virus 
capacity to autoreplicate. The Psi (ψ) sequence, responsible for the viral genome 
packaging, is localized exclusively on the transfer vector containing the exogenous 
gene, to further minimize the possibility to generate functional autoreplicant viruses. 
The expression of the exogenous gene was under control of a Doxycycline-inducible 
promoter. The used vectors for the lentiviral particles production were: a Gag/Pol-
containing pMDL vector, a pRev vector, a pVSV-G vector and the transgene-
containing transfer vector Tet-O-Fuw. Moreover, a prtTA vector, expressing for the 
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reverse tetracycline transactivator (rtTA) protein, was necessary, in conjunction 
again with the pMDL, pRev and the pVSV-G, to produce lentiviruses to combine in 
the infections with the Tet-O-Fuw-containing viruses in order to allow the 
Doxycycline induced expression (rtTA vector was supplied by Massimiliano 
Caiazzo, PhD; Istituto San Raffele, Milan). 
For all these vectors Gigapreps were made using the EndoFree Plasmid Gigaprep 
(Qiagen) following the manufacturer instructions. For the viral particles production, 
8.2x106 HEK293T cells were plated in 150mm x 25 mm dishes in DMEM 
(Invitrogen) supplied with 10%FBS (Euroclone), 25mM Hepes (Invitrogen), 
100U/ml Streptomycin (Sigma) and 100µg/mL Penicillin (Sigma). 24 hours later an 
80% confluence is generally obtained. Medium was replaced by ISCOVE medium 
(Invitrogen), 10% FBS, 100U/ml Streptomycin and 100µg/ml Penicillin. 3 hours later 
a 4 vectors co-transfection was made following the calcium phosphate transfection 
protocol. 
In details, for each dish, a solution was prepared containing 270mM CaCl2, 6,25μg 
pRev, 9μg pVSVG, 14,6μg pMDL and 32μg if insert containing transfer vector. After 
5 min incubation at room temperature, drop-by-drop, in low agitation, a 2xHBS pH 
6,95 (NaCl 280mM, Na2HPO4 1,5mM, HEPES 50mM) solution was added to the 
vectors mix. A 15 min room temperature incubation followed. Later, the entire 
solution was spread, drop by drop, in the culture medium and 293T cells were 
incubated at 37°C and 5%CO2. 12 hours later, medium was refreshed and reduced in 
its amount. 30 hours later, medium was harvested, filtered (0.22μm filters) and the 
ultra-centrifuged at 19400 rpm at 20°C for 2 hours (Optima L90K; Beckman 
Coulter). Lentiviruses-containing pellet was resuspended in PBS and stored at -80°C. 
Lentiviruses infectivity and the “maximum tolerated dose” were empirically 
determined through sequential infections on HEK 293T cells with increasing amounts 
of virus. 
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2.3.2 RNA extraction and reverse transcription 
RNA was extracted from cells using the TRI-REAGENT (Sigma) classic method as 
described by Chomczynski and Sacchi (Chomczynski and Sacchi 1987). RNA was 
treated with DNAase (Ambion) to eliminate possible DNA contaminations. The yield 
and the integrity of RNA were determined by spectrophotometric measurements and 
by agarose gel electrophoresis, respectively. For the reverse transcription 2µg of 
RNA were incubated for 5 min at 65°C with 6 μM random hexanucleotides as 
primers (New England Biolabs) in presence of 500 µM dNTP. Reverse transcription 
is performed with 200U of Moloney’s murine leukemia virus reverse transcriptase 
(M-MLV, New England Biolabs) in an appropriate buffer (50mM Tris-HCl pH 8,3, 
3mM MgCl2, 75mM KCl, 10mM DTT) supplemented with 40U of RNase inhibitor 
(New England Biolabs). Samples were incubated in a thermal cycler (Celbio) at 25°C 
for 10 min, 37°C for 50 min and finally at 70°C for 15 min in order to denature RNA-
cDNA hybrids. cDNA is diluted 1:5 in ddH2O prior to use. 
    
2.3.3 Quantitative PCR 
Analyses were carried out on triplicate samples for each experiment and they were 
processed separately. RT-PCR was performed on 4μl of previously diluted cDNA 
(1:5) template using the Power Sybr Green Master mix (Applied Biosystem), in 
presence of 0.5uM specific oligos. Synthetic oligonucleotides were synthesized by 
Primm. The experiments were performed on a 7900 HT Fast Real time PCR system 
(Applied Biosystem) with a thermal profile consisted of 2 min at 50°C, 10 min at 
95°C and 40 cycles of 15 sec at 95°C and 1 min at 60°C. All PCR data were 
normalized to the average of the reference gene hypoxanthine-guanine 
phosphoribosyltransferase (HPRT). All primers were designed using the Oligo7 
software and are listed in Table2. 
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Table 2. List of gene specific primers for qPCR analyses 
Gene Forward primer Reverse primer 
DAT TCTGGGTATCGACAGTGCCA GCAGCTGGAACTCATCGACAA 
DBH GACCGGCTACTGCACAGACAA GAGAGGCAAAGATGTGGATTCC 
Foxa2 ACGAGCCATCCGACTGGAG GGCGTTCATGTTGCTCACG 
GAD2 AGGGTTACTGATGTCCCGGAA ATGTTGGAGATGGCACCACC 
GFAP GAGGGACAACTTTGCACAGGA CCAGCCTCAGGTTGGTTTCAT 
HPRT TGCCCTTGACTATAATGAGTACTTCAG TTGGCTTTTCCAGTTTCACTAATG 
Lmx1a AACCAGCGAGCCAAGATGAA TGGGTGTTCTGTTGGTCCTGT 
Mash1 GCCAACAAGAAGATGAGCAAG CGTCGTGCTCGTCCAG 
Nestin AGCAACTGGCACACCTCAAGA CTCAGCCTCCAGCAGAGTCC 
Ngn2 ATCTGGAGCCGCGTAGGAT CATCAGTACCTCCTCTTCCTCCTTC 
Nurr1 GTGCCTAGCTGTTGGGATGG GTAAACGACCTCTCCGGCC 
OCT 3/4 AACCAACTCCCGAGGAGTCC CAGCAGCTTGGCAAACTGTTC 
Olig2 GGAGGAGATGAAGCGACTGGT GAGGCGCCGAGTGTGC 
Pitx3 GACGCAGGCACTCCACACC TTCTCCGAGTCACTGTGCTC 
PNMT GTGTATAGTCAGCATGCCTGCC CGAAGCTGGCGTTCTTTCTC 
Sox1 GGAAAACCCCAAGATGCACA CCTCGGACATGACCTTCCACT 
Sox2 AGGGCTGGACTGCGAACTG TTTGCACCCCTCCCAATTC 
Sox3 GCACATGAAGGAGTACCCGG TGTCCTTCTTGAGCAGCGTCT 
TH CTCACCTATGCACTCACCCGA GGTCAGCCAACATGGGTACG 
TPH1 ACAACATCCCGCAACTGGAG CACAGGACGGATGGAAAACC 
Vimentin CGCCCTCATTCCCTTGT GCGGTAGGAGGACGAGGACACA 
Vmat2 TTGCTCATCTGTGGCTGGG TGGCGTTACCCCTCTCTTCAT 
 
2.4 Chromatin Immunoprecipitation 
For chromatin isolation, midbrains were dissected from at least n.20 E12.5 mice 
embryos in ice cold PBS. The tissue was then weighted, homogenized using a glass 
potter and fixed in 1% formaldehyde in PBS at RT for 15 min to ensure crosslinking 
between proteins and DNA. Reaction was quenched with 125 mM glycine (Sigma) 
and tissue was washed three times with PBS supplemented with protease inhibitors 
(PI; Roche).  
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Pellets were resuspended in 1mL of lysis buffer (1%SDS, 50mM Tris-Hcl ph8, 
10mM EDTA) supplemented with PI and incubated in ice for 10 min. Subsequently 
0,5 mL of glass beads (Sigma) were added and tissue was incubated for additional 10 
min in ice then sonicated to shear chromatin. Sonication was optimized to ensure a 
200-500 bp average size. For this purpose a Soniprep150 disruptor (Sanyo) was used 
for 12-15 cycles 30’’on/30’’off with amplitude set to 11. After a 15 min centrifuge at 
13.000 rpm to remove cell debris, DNA concentration was measured to the 
spectrophotometer. Usually a 0,5-1µg/µL-concentration range is considered 
acceptable. To verify the shear size, 50 µL of chromatin were decrosslinked at 65°C 
for 30 min with the addition of 3 µL of proteinase K (50mg/mL; Sigma), DNA was 
extracted with phenol/chloroform and loaded on a 1,5% agarose gel for a 30 min run 
at 150V. The result should display a DNA smear with a major concentration between 
200bp and 500bp. 
For the IP, up to 60 µg of chromatin were precleared with 50µL of sheep anti-mouse 
IgG-conjugated Dynabeads® (Invitrogen) for 1,5h at 4°C in rotation, then 
immunoprecipitated in IP buffer (0,2M HEPES pH 8, 0,2M NaCl, 0,02 M EDTA, 
0,1% Deoxycholate Sodium, 1% Triton-X-100, 1mg/mL BSA and protease 
inhibitors) with 5 µg of anti-Mash1 (BD Pharmingen) or generic mouse IgG (Sigma) 
at 4°C ON in rotation. 50µL of input chromatin were processed separately as 5% 
input chromatin. The day after, the samples were incubated for 2h at 4°C in rotation 
with 50µL of Dynabeads® carrying the secondary antibody, to pull down the Mash1-
enriched chromatin. Subsequently, the magnetic beads, which are bounded to 
immunoprecipitated chromatin, were captured and washed 8 times with a modified 
RIPA buffer (50mM HEPES pH 7.6, 1mM EDTA, 1% NP-40, 0,7% Deoxycholate 
Sodium) containing 0,5M LiCl. Chromatin was eluted 10 min at 65°C with a buffer 
containing 10mM Tris pH 8 and 1% SDS, then beads were removed. The same 
procedure was applied to input chromatin. To remove proteins, the IP chromatin were 
treated with 3µL of proteinase K (50mg/mL; Sigma) and 11µL of 5M NaCl at 65°C 
ON. DNA is isolated with 1 volume of phenol/chloroform/isoamyl alcohol (25:24:1; 
Euroclone) and precipitated with 5µL of glycogen, 50µL of 3M Sodium Acetate 
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pH5.2 and 900µL of isopropanol. DNA is therefore resuspended in 100-200µL of 
sterile ddH2O. 
For the analysis of the enrichment, 5µL of DNA were analyzed with RT-PCR as 
described above. The primers for the putative binding site, the positive control 
sequence and the negative control sequence were designed with Oligo7 software to 
with an average size of 20-24nt, a median Tm of 58-60°C and a 40-70% GC content. 
All used primers are listed in Table3. The input Ct value adjusted for the input 
percentage (Input Ct + Log25) was subtracted from all Ct values to normalize. ChIP 
efficiency was calculated as the ratio of precipitated sequence over total amount of 
sequence in the input chromatin.  The data were plotted as means of at least two 
independent ChIP assays and three independent amplifications; error bars represent 
standard deviations. 
 
 
Table 3. List of used primers for ChIP analysis 
Binding site Forward primer Reverse primer 
TH1 GCTGCCCAATTATCCCTAAG GTAGGCACAGAATATGTACTAGA 
TH2 GACCTCAAGTGCACCTCTTC CCTCAGCTCCCAACACTTCT 
TH3 AGGTGCTGGGAATAAGGTGG TGTCTTAGGGAAGGGCTACA 
NBRE TGCCGAAAGGTTAAATCCACA CCTGGCGTTTGCTCAGCTGG 
Dll1 GCGTGGCTGTCATTAAGG GGTGCTGTCTGCATTACC 
 
2.5 Western Blotting 
To verify the enrichment of Mash1, 15µL of IP samples were decrosslinked at 65°C 
ON and protein concentrations were measured with Bradford assay. 
Proteins were separated on 12% SDS-polyacrilamide gel and transferred to PVDF 
membranes (Millipore). Filters were probed for 2h at room temperature or overnight 
at 4°C with the anti-Mash1 antibody (1:500; BD Pharmingen). After washing, 
immunoblots were incubated with anti-mouse IgG antibodies (Amersham, 1:10000) 
and the reaction detected with the ECL plus procedure (Amersham).  
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2.6 Luciferase assays 
HeLa cells or A1 cells were plated in 48-well plates (BD Biosciences) at a density of 
40.000 cell/well. For the promoter analysis 0,4µg of the pGL3-NBRE plasmid and 
0,4µg of 3xFLAG-Nurr1 and pcDNA3-Mash1 plasmids were co-transfected, using 
Lipofectamine 2000®(Invitrogen). I used a Renilla luciferase vector carrying the 
Simian vacuolating virus 40 promoter (pRL-SV40) as an internal control vector. For 
the dual (firefly and Renilla) luciferase assays, cells were extracted with passive lysis 
buffer (Promega). 10µL of cell extract were used for firefly and Renilla luciferase 
assays using the Dual-Luciferase™ Reporter Assay System (Promega) and the ratio of 
luminescence signals from the reaction mediated by the firefly luciferase reporter to 
those from the reaction mediated by the Renilla luciferase was calculated. For each 
reporter the luciferase activity of the empty pGL3 vector was subtracted. The data 
were performed in triplicate.  
 
2.7 Bioinformatics analysis 
To analyze TH promoter, an 8101bp sequence was retrieved on the NCBI database 
(http://www.ncbi.nlm.nih.gov/nucleotide/; ID: JN963248.1).  
This sequence was inserted into Regulatory Sequence Analysis Tool (RSAT; 
http://rsat.ulb.ac.be/rsat/; Turatsinze et al. 2008) setting a position weight matrix 
(PWM) retrieved on Jaspar core database (http://jaspardev.genereg.net/; Mathelier et 
al. 2014). This matrix, Ascl2_1 (ID PB0003.1), encodes for a sequence CAGCTG in 
accordance with Castro et al. (Castro and Guillemot 2011). The resulting sequences 
have been ordered by increasing p-values and position weight scores and the more 
significant were chosen. 
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2.8 Statistical analyses 
For all experiments, analysis of variance was carried out, followed by post hoc 
comparison (ANOVA, Bonferroni-test). A value of p≤0.05 was considered 
significant. Data were expressed as mean ± SE. At least three independent replicates 
were used for RT-PCR and luciferase assays, and at least two replicates were used for 
cell counts and ChIP experiments, with data expressed as mean ± SD.  
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3. RESULTS 
 
3.1 Neural stem cells isolation, culture and characterization 
One of the difficulties in identifying and studying stem cells is their poorly defined 
physical nature, which affects our ability to directly measure their presence and to 
monitor their activity. This problem has been overcome by a functional 
characterization rather than a physical or morphological observation.  
In order to obtain an in vitro model system to study the differentiation of mDA 
neurons, neural progenitor/stem cells have been isolated from midbrains of 
embryonic day 12.15 (E12.5) mouse embryos. Embryonic cortex derived cells were 
also used as a comparison to evaluate the influence of the regional commitment on 
the specification of the neuronal subtype. However as described below, also these cell 
are able, under appropriate conditions, to generate TH positive neurons. The choice 
of the embryonic stage was driven by practical and theoretical reasons: TH+ cells, 
considered in the midbrain precursors of DA neurons, appear in mouse around E9. At 
E10-E11 their distribution is similar to that of cell clusters of A9 and A10 areas in the 
adult mouse while only at E13 these appears as separated areas (Di Porzio et al. 
1990). Nevertheless cells obtained at E13 appear being more responsive to 
differentiation factors than those from E11 (data not shown). Thus I choose E12.5 as 
the stage with the better balance between precursors yield and responsiveness to 
differentiation factors. Cells were derived both by wild type (WT) and TH-GFP C57 
BL/6 mice, a transgenic mouse line carrying the fluorescent protein EGFP under the 
control of TH promoter (Sawamoto et al. 2001).  
Initially, to characterize the isolated cells, I performed a functional assay to assess 
their ability to proliferate, self-renew and to give rise to neurons, astrocytes and 
oligodendrocytes. The neurosphere assay takes account of these three characteristics. 
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3.1.1 Neurosphere-derived cells are able to self-renew 
Cells derived from embryonic tissue were plated at low density (≈ 30.000 cells/mL) 
in a serum-free culture medium containing the mitogens bFGF and EGF. In these 
conditions they undergo cell division giving rise to floating aggregates, deriving from 
a single cell, called neurospheres. These aggregates show a characteristic 3-D 
structure with small protrusions at the edges and after 5-7 days in vitro (DIV), reach a 
≈150 µm diameter, feature that demonstrate the ability of isolated cells to proliferate 
(Fig.9).  
 
 
Figure 9. Cortex-derived neurospheres at 5 DIV. After 5 DIV clonal aggregates reach ≈150 µm diameter 
and show a characteristic structure. Arrows indicate characteristic small protrusions. 
 
Once the spheres reached the appropriate dimensions, they were collected, 
dissociated and re-plated at the same initial density to monitor the formation of 
secondary spheres. At every passage, cells were counted to assess the ability to 
proliferate and self-renew.  As shown in Fig.10, neurospheres derived from cortex 
have shown a 7,21-fold increase at every passage versus a 3,44-fold increase of 
midbrain-derived cells, a feature suggesting a lower proliferative capacity of the 
latter.  
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Nonetheless, the ability of the cells to proliferate at every passage and reform spheres 
with no significant decrease of the final cell density  demonstrates the clear ability of 
both cell types to self-renew (Fig.10). 
 
 
Figure 10.  Neurosphere self-renewal assessment. The chart shows the trend of neural stem cells derived 
from cortex (CTX) and midbrain (MB) to proliferate and to maintain the same density during passages. 
Midbrain-derived cells (red line) show a minor propensity to proliferate as compared with cortex-derived 
cells (blue line). 
 
3.1.2 Proliferating neurosphere-derived cells express progenitor markers 
To evaluate the phenotypic stability of the cultures, I checked, during passages, for 
the expression of specific genes known as markers for neuronal progenitor and 
mature neurons. Several markers are known to be expressed in NSC, such as Nestin 
(Alvarez-Buylla et al. 2001; Campos 2004), Sox-2 (Graham et al. 2003) and Glial 
Fibrillary Acidic Protein (GFAP), a protein expressed principally by astrocytes but 
also by NSCs (Doetsch 2003a; Doetsch 2003b). In my experiments, Nestin, Sox-2 and 
GFAP were chosen as indicators of the immature phenotype, while β−ΙΙΙ tubulin 
(Tuj1) was selected as marker of post-mitotic neurons. These markers allowed 
monitoring the NSCs in culture to ensure that they maintained a low degree of 
differentiation during passages.  
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Immunostaining experiments have shown that Nestin and Sox2 as well as GFAP 
were consistently expressed (Fig. 10-A). Notably Nestin and Sox2 transcripts were 
highly expressed during passages although appear to fluctuate. In particular, Sox2 
seems to rapidly increase after the first plating (Fig.10-B). This is consistent with the 
hypothesis that only neural progenitor cells are able to amplify under the effect of 
mitogens. Undeniably, Tuj1 levels rapidly decrease after the first plating and 
maintain very low levels during passages (Fig. 10-B) in agreement with the previous 
hypothesis. The same trend in all markers was observed in both midbrain- and cortex-
derived cultures, suggesting that NSC, isolated from either areas show similar 
features despite the different regional identity. 
 
 
 
 
Figure 11. Neurospheres express progenitor markers. Markers of immature proliferating cells, such as 
Nestin, Sox2 and GFAP (A) appear to be regularly expressed in whole neurospheres. In (B) it can be 
observed that the expression of Nestin and Sox2 is stable through the passages while it can be noted the 
decrease of the mature neurons marker Tuj1 just after the first plating.  
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3.1.3 Neurosphere-derived cells are multipotent 
As pointed out above, the proof for the multipotency of neurosphere-derived cells is 
the ability of the latter to form neurons, astrocytes and oligodendrocytes when 
allowed to differentiate. Neural progenitors proliferate in culture under the effect of 
mitogen factors such as bFGF and EFG, but they start to differentiate upon mitogens 
withdrawal and addition of 1% serum (Rietze and Reynolds 2006).  
Thus, using semi-quantitative PCR and immunostaining, I evaluated, upon 
differentiation of the cells, the expression of Tuj1, specific for neuronal linage, the 
astrocytic marker GFAP and the bHLH factor Olig2, specifically expressed in 
olygodendrocytes. Both cortex- and midbrain-derived cells are able to differentiate in 
the three lineages, as shown by immunostaining and gene expression analysis for the 
indicated markers (Fig.12). In particular, differentiated neurospheres from both areas 
show a similar percentage of neurons (3%), astrocytes (62%) and oligodendrocytes 
(1,3%). This result is consistent with previous works (Reynolds and Weiss 1992) 
showing the prevalence of astrocytic lineage in differentiated cultures.  
 
 
 
A different approach in differentiating neurospheres is to induce a specific phenotype 
independently from the others. The treatment with specific growth factors can drive 
the progenitor cells towards a specific fate (Johe et al. 1996), in particular Platelet-
derived growth factor (PDGF) is able to induce a neuronal phenotype, Ciliary 
neurotrophic factor (CNTF) is involved in the generations of astrocytes and 
Triiodothyronine (also known as T3) induces the formation of oligodendrocytes.  
I therefore treated midbrain and cortex-derived cells with PDGF or CNTF to increase 
respectively neuronal and astroglial fate and analyzed expression of markers. 
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Subsequently, I evaluated mRNA and protein expression of neuronal, astroglial and 
oligodendroglial markers. Analysis for neuronal markers showed that PDGF 
selectively induced neuronal fate leading to a strong increase in Tuj1 expression both 
in immunolabeled cells and in Real Time PCR experiments (Fig.13-A and 13-B). In 
the same way CNTF was efficient in inducing astroglial lineage differentiation, 
however it has a positive effect also on neurons generation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Neurosphere multipotent differentiation. Representative images of neurosphere-derived cells 
differentiated upon withdrawal of mitogens and serum addiction. On the left are showed immunostainings 
for neuronal marker Tuj1 (red) and the astroglial marker GFAP (green). On the right side are represented 
relative mRNA amounts of linage markers compared with the expression of progenitors marker Nestin. 
Midbrain-derived cells are showed in A and B, cortex-derived cells are showed in C and D. 
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As shown in Fig.13, PDGF treatment led to a higher differentiation of Tuj1+ cells 
with very few or no GFAP+ cells. On the other hand, in CNTF treated cultures I 
observed a strong increase in GFAP+ cells. Interestingly the massive presence of 
astrocytes could exert a trophic effect on neurons, also under these culture conditions, 
and favors a little neuronal differentiation, since neurons are present, albeit in small 
numbers, and survive as well. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. PDGF and CNTF treatment on neurosphere-derived cells. In A and B are represented 
mRNA levels of neuronal marker Tuj1 and astroglial marker GFAP following the treatment with PDGF or 
CNTF compared with an untreated control. Note that CNTF treatment results in an increase of neuronal 
types due to trophic action of astrocytes on the latter. In C and D Immunostaining for the same markers 
confirm the gene expression analysis as PDGF treatment results in the generation of only neurons (Tuj1+) 
while CNTF treatment increase the generation of astrocytes (GFAP+)  with several neurons. 
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3.2 Differentiation of neural stem cells into dopaminergic neurons 
To elucidate the molecular events underlying the differentiation of dopaminergic 
neurons under these experimental conditions, I established an in vitro paradigm that 
recapitulates, at least in part, the main molecular events occurring in vivo. First, 
neurosphere-derived cells are allowed to proliferate while exposed to the effect of 
known DA inductors in order to obtain proliferating DA precursors; then, upon 
mitogen withdrawal, cells are exposed to a number of factors that ensure DA survival 
and maturation. This basic protocol has been used as a platform to test the effect of 
Mash1 and Nurr1 overexpression (Fig.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. DA differentiation protocol. The scheme represents the protocol that consists of an induction 
and proliferation phase driven by the action of the mitogen bFGF and of the morphogens SHH and FGF8. 
During this phase TFs were expressed using inducible lentiviral vectors. Transgene expression is achieved 
by the addition of doxycycline  in the second phase, in which the differentiation of DA precursors is 
achieved through the action of AA, GDNF and cAMP which have the task of ensuring the survival and 
maturation of post-mitotic DA neurons. 
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3.2.1 Induction of the dopaminergic phenotype by SHH and FGF8 
treatment 
To obtain dopaminergic neurons from NSC derived from embryonic brains, cells 
were exposed to the actions of morphogen factors SHH and FGF8. In the first part of 
the protocol, cells are proliferating under the effect of bFGF and exposed to 50 
ng/mL SHH and 10ng/mL FGF8. This phase is necessary for the induction of 
dopaminergic fate. The second stage is characterized by the withdrawal of the 
mitogen and the addition to the culture medium of Ascorbic Acid and GDNF, two 
factors that improve survival. In this way cells stop to proliferate and start to 
differentiate. However this protocol, by itself, has a moderate efficiency in promoting 
DA differentiations. As shown in Fig.15, the relative quantification of mRNA 
expression shows only a 2-fold increment of TH.  
 
 
Figure 15. Relative expression of tyrosine hydroxylase after SHH and FGF8 treatment: addition to the 
culture medium of the morphogens elicits a 2-fold increment in TH expression 
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3.2.2 Overexpression of Mash1 and Nurr1 in neural progenitors enhance 
Tyrosine Hydroxylase gene expression 
To study the effect of Mash1 and Nurr1 on the differentiation of DA neurons, I 
prepared inducible lentiviral vectors carrying their sequences. The use of inducible 
lentiviral vectors allows an efficient transduction of exogenous genes combined with 
the possibility to control gene expression by adding doxycycline to the medium.  
Cells dissociated from midbrain and cortex-derived neurospheres were harvested 
from passage 2-4 cultures, plated at low density and allowed to proliferate for 6 days 
in presence of SHH and FGF8. During this stage Mash1, Nurr1, both the genes and 
an empty control vector were transduced to the cells. Their expression was induced 
only during the differentiation stage by adding doxycycline. Following the 
withdrawal of the mitogens and the induction of the exogenous genes, cells were 
allowed to differentiate for 6-8 days.  
As expected the semi-quantitative PCR analysis shows a great increase in TH mRNA 
expression following Nurr1 infection. Infection with Mash1 alone resulted in a 2-fold 
increase (compared with the control) but interestingly, co-infection of Mash1 and 
Nurr1 resulted in a further 3-fold increase when compared with Nurr1 alone (Fig.16).  
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Figure 16. Mash1 and Nurr1 enhance TH expression. (A,B) Immunofluorescence showing TH 
expression in treated cells, counts are displayed in the graph in (D). (C) Double infection with Mash1 and 
Nurr1 lentiviruses results in a massive increase in TH mRNA expression both in cortex (CTX) and in 
midbrain (MB) derived cells.  
 
Remarkably, these results were obtained not only with midbrain-derived cells but 
also with those derived from the cortex, a brain area that normally does not give rise 
to DA lineage cells. This data could indicate a specific cooperative effect on TH 
expression that is independent from regional commitment. 
The immunofluorescence for the GFP, expressed under the control of TH promoter 
confirms the effects of the co-expression of Mash1 and Nurr1 that result in 
significantly higher TH expression when compared with Nurr1 alone.    
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In control cultures and Mash1 treated cultures I could not detect expression of TH+ 
cells thus confirming that Mash1 alone is not sufficient to induce DA fate (Fig.16). 
Furthermore, when I counterstained differentiated cells with an antibody that 
recognize Tuj1, a marker expressed only in post-mitotic neurons, I could confirm that 
the majority of TH+ cells were post-mitotic neurons overexpressing both Nurr1 and 
Mash1 (Fig. 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Generated cells are post-mitotic. Immunofluorescence shows that treated cells express the same 
levels of the post-mitotic neuronal marker Tuj1. 
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3.2.3 Mash1 and Nurr1 overexpression increases the expression of 
dopaminergic markers 
To assess the identity of the differentiated cells, I also analyzed the expression of 
genes that are distinctive of the dopaminergic phenotype, such as the dopamine 
transporter (DAT), the vesicular monoamine transporter Vmat2 and Pitx3, a specific 
marker of midbrain dopaminergic neurons (Fig.18-A). Interestingly, I observed a 
marked difference between cortex and midbrain-derived cultures. The latter show 
higher levels of dopaminergic transcripts than the former condition, suggesting that 
the appropriate cellular context allows a more extensive functional maturation of DA 
neurons. It is interesting to note that despite these differences, the overexpression of 
single transcription factors or the co-overexpression of both TFs have shown a 
similar trend in both types of cultures. Pitx3 and Vmat2 expression showed a slight 
increase when cells are co-treated with Nurr1 and Mash1, while a significant increase 
of DAT levels was observable only with Nurr1 overexpression since co-treatment 
with Mash1 had not any additive effects. Pitx3 expression, almost absent in cortex-
derived cultures, does not seem to undergo significant variations, with the exception 
of a significant increase in midbrain-derived cultures co-treated with Nurr1 and 
Mash1. Nevertheless, the relative levels of expression of all observed markers are 
low. One possible explanation of these phenomena could be that although treated 
cells are post-mitotic, they are still completing the final phase of maturation. 
Moreover, to exclude a differentiation towards other phenotypes, I checked the 
mRNA expression of non-dopaminergic genes such as Tryptophan hydroxylase 1 
(Tph1) for serotonergic phenotype, the adrenergic marker Phenylethanolamine N-
methyltransferase (PNMT) and the Dopamine-β-hydroxylase (DBH) which is a 
marker for noradrenergic neurons. As showed in Fig.18-B, the expression of these 
markers was found significantly low, either in cortex- and midbrain-derived cells, 
indicating that the related phenotypes were not induced by the treatment (Fig.18-B)   
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Figure 18. mRNA expression of dopaminergic and non-dopaminergic genes. In the charts are compared 
the levels of dopaminergic genes in cortex (CTX) and midbrain (MB) derived cultures after treatment with 
Nurr1 and Mash1. Transcripts for other phenotypes (B), such as serotonergic  
 
3.2.4 Mash1 has a positive effect on Nurr1-induced expression of TH 
Altogether the above described data seem to suggest a cooperative action of Mash1 
and Nurr1 on the expression of TH. Since Nurr1 is a direct activator of TH 
transcription, I wanted to assess the effect of exogenous Nurr1 on TH expression in 
absence or presence of Mash1. For this purpose, I immunolabeled differentiated cells 
with an antibody directed versus Flag, an epitope that is fused to the N-terminal of 
the Nurr1 transgene. Thus I have been able to visualize the presence of Nurr1 in the 
nuclei of TH+ cells.  
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Unexpectedly, although Nurr1 was present in the nucleus of treated cells, not all the 
Nurr1+ cells expressed also TH. Interestingly, when Mash1 was co-expressed with 
Nurr1, I observed a significantly increase in the number of Nurr1+ cells that were also 
positive for TH. This effect is in favor of my working hypothesis regarding the 
cooperation between Mash1 and Nurr1,  and suggests that Mash1 could modulate the 
activity of Nurr1 on TH expression. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Immunostaining for Nurr1 and TH on treated cultures: Image shows midbrain-derived cultures treated 
with Nurr1 alone (A) compared with double treated cultures (B). In C are represented cell counts showing the 
percentage of TH+cells on Nurr1+cells.  
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3.2.5 The mesencephalic cell line A1 efficiently responds to the 
overexpression of Mash1 and Nurr1 
The heterogeneity and the pre-existence of a regional induction of neurosphere-
derived cells can affect the efficiency of the protocol resulting in a low percentage of 
TH+ neurons as compared on the whole culture. To overcome these difficulties, I 
repeated the overexpression experiments in the immortalized cell line mes-c-myc A1 
(A1). A1 cells are derived from embryonic midbrain and apparently retain the 
characteristics of neural progenitors. They are capable to differentiate in neurons and 
glia (Colucci-D’Amato et al. 1999). The principal advantage of this culture is the 
homogeneity of the cells and the responsiveness to differentiating conditions with a 
relative low cell mortality. As shown by qPCR analysis (Fig.20), the co-
overexpression of Mash1 and Nurr1 resulted in a major increase in TH expression 
compared with the expression of the individual transcription factors. This data 
faithfully replicates those obtained on neurosphere-derived cultures, but in this case 
the levels of TH are 10-fold higher. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Enhancement of TH expression in A1 cells. Mash1 and Nurr1 co-overexpression enhance TH 
levels more than Nurr1 alone or Mash1 (small chart on the left) alone. 
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Also in the A1 cells, the relative expression of dopaminergic genes was enhanced by 
the double treatment as in the neurosphere-derived cultures (Fig.21). In particular, 
Vmat2 (Fig.21-A) and DAT (Fig.21-C) followed the same trend observed in 
neurospheres with the former responding to the action of both transcription factors 
and the latter responding to the action of Nurr1 alone. Pitx3 mRNA (Fig.21-B) 
responded to individual overexpression of Mash1 and Nurr1 with a ≈3-fold increase 
compared to untreated control. 
 
 
 
 
 
 
 
 
 
Figure 21. Expression of dopaminergic genes in A1 cells. Co-overexpression of Mash1 and Nurr1 
increase the expression of Pitx3(A), VMAT2 (B) and DAT (C) 
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3.3 Mash1 binds to the TH promoter 
Altogether the data showed a new cooperative mechanism of Mash1 and Nurr1 in the 
differentiation of dopaminergic neurons. Their combined action is most evident on 
the expression of TH rather than other dopaminergic markers indicating that the two 
transcription factors could interact to enhance the expression of this gene. Thus, I 
hypothesized that the two TFs could interact at transcriptional level on the TH 
promoter. The cooperation can be explained by two models (Fig.22): the first model 
(Fig.22-A) provide for a cooperation between Mash1 and Nurr1 through a direct 
interaction in the context of the transcriptional complex present on Nurr1 binding site 
(NBRE); the second model (Fig.22-B) is based on previous literature data showing 
the binding of Mash1 to specific enhancer sequences (E-box) modulate the activity of 
its target promoters (Nakada et al. 2004; Kageyama et al. 2005; Poitras et al. 2007). 
Considering these literature data, the hypothesis showed in Fig.21-B appears to be 
more suitable. 
According with these hypothesis, I proceeded to demonstrate first the presence of 
putative binding sites for Mash1 by analyzing the sequence of TH promoter, then I 
verified the binding of Mash1 with these sites or, indirectly, with NBRE, taking 
advantage of chromatin immunoprecipitation (ChIP) experiments. 
 
 
Figure 22. Hypothetical models to explain Mash1 and Nurr1 cooperation. Schematic representation of 
hypothetical mechanisms of action of Mash1 and Nurr1 for the activation of TH expression: A) Mash1 
interacts physically with Nurr1 within the transcriptional complex  present on NBRE binding site to 
modulate the activity of the complex; B) Mash1 binds an enhancer sequence (E-box) distal from NBRE to 
modulate Nurr1-dependent transcription of TH via an indirect mechanism. 
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3.3.1 The TH promoter contains three putative E-box for Mash1 
As pointed out above, Mash1 is known to bind a conserved motif called E-box 
(CANNTG) that functions as enhancer in many promoters. To verify their presence 
on TH promoter, I retrieved a 8101bp sequence on the NCBI database 
(http://www.ncbi.nlm.nih.gov/nucleotide/; ID: JN963248.1) which comprises the 
5’upstream sequence of mouse TH gene and part of the first exon. According with 
Kim et al. (Kim et al. 2003d), the transcription start site (TSS) is positioned at 
7986bp on the sequence. 
I therefore analyzed this sequence availing of the Regulatory Sequence Analysis Tool 
(RSAT; http://rsat.ulb.ac.be/rsat/; Turatsinze et al. 2008), a software able to scan a 
promoter sequence to find regulatory elements specific for a given TF. The software 
uses a position weight matrix (PWM) to analyze the statistical significance of 
retrieved sequences. For the analysis, I retrieved the Ascl2_1 (ID PB0003.1) matrix 
on Jaspar core database (http://jaspardev.genereg.net/; Mathelier et al. 2014; Fig.22). 
Subsequently I chosen the three sequences with lowest P-value (i.e. the highest 
significance) out of 501 sequences resulted from the analysis. These sequences, 
which I called TH1, TH2 and TH3, are located respectively at -2800 bp, -4700 bp and 
-7700 bp from the TSS (Table 1).  
 
 
Figure 23. Position weight matrix for Mash1. Graphical representation of the average binding site for 
Mash1, the height of each base is correlated with the conservation in that determined position.  
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Table 4. RSAT analysis of TH promoter for Mash1 binding sites.   
#seq_id start end sequence weight Pval ln_Pval sig\ 
TH -2923 -2907 TTTAGCAGCTGCAGCTG 11,4 0,00000033 -14,924 6.481\ 
TH -4690 -4674 GACCGCAGCTGGTGCTG 8,5 0,000031 -10,382 4.509\ 
TH -7830 -7814 AGCAGCAGCTGTCATGA 8,1 0,000047 -9,965 4.328\ 
TH -2367 -2351 TAGGCCAGGTGCTACTT 7,2 0,00011 -9,115 3.959\ 
TH -7084 -7068 GGCAGCAGGTGTTAGAG 7 0,00014 -8,874 3.854\ 
TH -2520 -2504 TCTACCAGCTGTCTCTC 6,8 0,00016 -8,74 3.796\ 
TH -4728 -4712 ACTTTCAGCTGCCCAAT 6,7 0,00018 -8,623 3.745\ 
TH -7833 -7817 CATAGCAGCAGCTGTCA 6,4 0,00023 -8,377 3.638\ 
TH -4756 -4740 CTGATCAGCAGCTCTTG 6,3 0,00025 -8,294 3.602\ 
TH -4645 -4629 CGAGGCTGCTGCTCCAT 6,3 0,00025 -8,294 3.602\ 
TH -3064 -3048 CTTCCCAGCTACTCCTC 6,3 0,00025 -8,294 3.602\ 
TH -5696 -5680 CACTCCACCTGTCACAT 6,2 0,00027 -8,217 3.569\ 
TH -4753 -4737 ATCAGCAGCTCTTGCCT 6,2 0,00027 -8,217 3.569\ 
TH -4687 -4671 CGCAGCTGGTGCTGTCT 6,1 0,00029 -8,146 3.538\ 
TH -3388 -3372 GGCAGCAGCTTCCACAC 5,9 0,00034 -7,987 3.469\ 
TH -2554 -2538 GCCCACAGATGCTTTAG 5,8 0,00037 -7,902 3.432\ 
TH -6392 -6376 CTCCACACATGCAGAAG 5,8 0,0004 -7,824 3.398\ 
TH -7647 -7631 AGGCCCAGCTGTGAAAT 5,2 0,00059 -7,435 3.229\ 
TH -1315 -1299 TCTGGCTCCTGCTAATA 5,2 0,00059 -7,435 3.229\ 
TH -3379 -3363 TTCCACACCAGCCGCAC 5,1 0,00063 -7,37 3.201\ 
 
 
3.3.2 Mash1 binds two sites on TH promoter 
To verify the binding of Mash1 with the putative sequences, I performed a ChIP 
assay on whole chromatin isolated from E12.5 mouse midbrains. Indeed at this stage, 
in which DA progenitors are switching to post-mitotic phase, both Mash1 and Nurr1 
are co-expressed in midbrain; nonetheless E12.5 is the stage in which I isolated NSCs 
for the experiments showed above. The demonstration of the in vivo binding of 
Mash1 with TH promoter would firstly explain the results obtained in neurospheres 
and finally would provide a strong indication that this mechanism is involved in the 
switch of proliferating DA progenitors to post-mitotic phase. Thus, I 
immunoprecipitated (IP) the isolated chromatin using an anti-Mash1 antibody or a 
nonspecific IgG as mock control and I verified the enrichment of Mash1 by a 
Western Blot experiment (Fig.23-A) confirming the efficiency of the reaction. I 
therefore performed a semi-quantitative PCR analysis on isolated DNA to verify the 
enrichment of the sequences in the IP. Dll1, a known Mash1 target (Castro et al. 
2006), was used as positive control.  
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Noticeably, Mash1 was found to bind TH1 and TH2 sequences with a 9-fold and a 7-
fold increase respectively as compared with the mock (Fig.23-B) while no significant 
enrichment of TH3, the more distal binding site, was found.  
 
 
 
 
 
 
Figure 24. ChIP analysis of the binding of Mash1 to TH enhancers: A) Western Blot comparing 
Mash1-IP with mock-IP, evidencing  the high enrichment of the first. B) Histogram represents enrichment 
of Mash1 on predicted binding sites of TH promoter. IP efficiency was calculated as the ratio of 
precipitated sequence over total amount of sequence in the input chromatin. 
 
I also analyzed whether Mash1 was also enriched at the NBRE, the specific binding 
site for Nurr1 (Fig.23-B; Volpicelli et al. 2012), the IP showed that Mash1 was not 
enriched. This result indirectly indicates that there is not a physical interaction 
between Mash1 and Nurr1.  
This observation was also supported by data I obtained in the lab using a reporter 
assay in which the NBRE sequence is cloned upstream of the luciferase gene. Upon 
co-transfection of the reporter with plasmids encoding for Nurr1 and Mash1 in the 
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immortalized cell line HeLa and in the more context-specific A1 cell line I could not 
observe a significant increase of reporter activation (Fig.24).  
Altogether these data demonstrate that Mash1 seems to enhance Nurr1 transcriptional 
activity through the binding to the TH promoter rather than through a direct 
interaction with Nurr1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. NBRE luciferase assay. Relative reporter activity of NBRE following transfection of Mash1 
and Nurr1 in HeLa cells (A) and A1 cells (B). The binding-defective mutant Nurr280-281 was used as 
negative control and the activity of each gene was compared to relative empty vectors and to empty reporter 
vector. 
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4. DISCUSSION 
 
The brain is a very sophisticated machine whose fine architecture is the result of an 
orchestrated developmental plan, which is necessary to drive a single totipotent cell 
to give rise to a functional organism. Since the brain is composed of about 1011 
neurons with different specific and integrated functions, many efforts have been 
made to understand how, during development, single classes of neurons acquire their 
particular phenotype and how their function is then integrated into a complex 
environment.  
During my PhD thesis, my research has been aimed to untangle the molecular events 
driving the development of the neurons producing the catecholamine dopamine (DA). 
Dopaminergic neurons are an anatomically and functionally heterogeneous class of 
cells, with a broad distribution. The most prominent source of DA neurons is the 
midbrain where they are organized in three principal nuclei. As outlined in the 
introduction, of particular interest are the neurons residing in the substantia nigra and 
in the ventral tegmental area which give rise to the nigrostriatal pathway and the 
mesocorticolimbic pathway. Alterations of these circuits are involved in serious 
neurological and psychiatric diseases. 
I have already discussed how the development of midbrain dopaminergic (mDA) 
neurons is a complex multi-step process in which cell-intrinsic factors as well as 
environmental cues are integrated in an accurate space-time sequence to define their 
phenotypic and functional specificity. Many researches in the last decades have been 
aimed to characterize the molecules involved in this process, leading to the 
identification of a number of transcription factors (TFs) able to orchestrate induction, 
specification, differentiation and maturation of mDA neurons. Nevertheless the 
hierarchy of network interactions underlying their differentiation still needs to be 
further elucidated.  
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A literature survey suggested to me to focus on the transcription factors Nurr1 and 
Mash1, which could be involved in the switch from the mitotic specification stage to 
the post-mitotic differentiation phase. 
Previous works from our laboratory and others have well established that the orphan 
nuclear receptor Nurr1 is expressed in mDA post-mitotic progenitors starting from 
E10.5 and its expression persists in the adult brain. Its absence leads to a specific loss 
of DA neurons (Zetterström et al. 1996; Saucedo-Cardenas et al. 1998). Indeed, 
Nurr1 is a direct regulator of genes essential for dopaminergic function, such as TH, 
the dopamine transporter DAT and the vesicular monoamine transporter, Vmat2 
(Sacchetti et al. 2001; Kim et al. 2003b; Colebrooke et al. 2006). 
The bHLH factor Mash1 (Ascl1), is a well-known proneural factor since it is 
essential for neuronal specification in early developmental stages in a broad range of 
brain areas (Kageyama et al. 1997; Bertrand et al. 2002). It’s expression is detectable 
in the midbrain from E9-E10 until the early post-mitotic phase (Vernay et al. 2005). 
In addition to the generic neurogenic action, several lines of evidence have shown 
that it is also involved in specifying neuronal subtype identities . Interestingly, Mash1 
is co-expressed with Nurr1 in a subset of AHD2+ DA progenitor cells in early ventral 
midbrain (Park et al. 2006a) while Mash1 and Nurr1 have been shown to be 
important in the reprogramming of somatic cells into dopaminergic neurons (Caiazzo 
et al. 2011). 
Given these observations, the present work was driven by the hypothesis that Mash1 
and Nurr1 may cooperate during the dopaminergic lineage commitment, in the switch 
from the specification phase to the post-mitotic differentiation phase, triggering the 
molecular events leading to the correct development of fully differentiated midbrain 
DA neurons.  
Following the isolation of neural stem/progenitor cells (NSCs) from E12.5 mouse 
midbrain and cortex using the neurosphere assay, under the effect of the mitogens 
bFGF and EGF, I was able to select only proliferative multipotent neural progenitors, 
according to results from other laboratories (Reynolds and Weiss 1992; Rietze and 
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Reynolds 2006). Hence, using functional assays I have assessed the identity of these 
cells.  
In first instance, my results demonstrate the persistent ability of the cells to self-
renew through serial passages, and gave rise to secondary spheres. The higher 
proliferation rate that I observed in cortex-derived cells, a seven-fold increase, when 
compared to midbrain-derived cells, which showed a three-fold increase, suggested a 
minor proliferative capacity of the latter. Nevertheless this proliferative trend was 
stable during serial passages, a feature that demonstrates the self-renewal of the cells. 
That cortical precursors show a higher proliferation rate in my neurosphere-derived 
cell cultures is not surprising, since also in vivo the formation of the cortex, in mice 
and even more in humans, is consequent to the expansion of a precursor population 
(Chenn and Walsh 2002). In parallel experiments I have demonstrated that both 
cortex- and midbrain-derived cells stably express neuronal progenitor markers, such 
as Nestin and Sox2, during passages while the post-mitotic neuronal marker βIII-
tubulin (Tuj1) shows a dramatic decrease after the first passage and remains stably 
low-expressed. These results indicate that both precursor populations have immature 
properties. I also demonstrated the multipotency of neurosphere-derived cells, upon 
mitogens withdrawal and serum addition, by showing that they are able to give rise to 
the three types of neural lineages, that are neurons, which are positive for Tuj1, 
GFAP-positive astrocytes and oligodendrocytes expressing Olig2. In my 
experimental conditions also the relative representation of neurons (3%), astrocytes 
(62%) and oligodendrocytes (1,3%), either in cortex- and midbrain-derived cells, is 
consistent with literature data (Reynolds and Weiss 1992; Rietze and Reynolds 
2006).  
Once I have ascertained the multipotent identity of the cells, my aim has been 
directed to push neurosphere-derived cells towards DA fate establishing a 
differentiation paradigm. Therefore I have derived neurospheres from TH-GFP mice, 
which have the great advantage of enabling the identification, by 
immunofluorescence, of cells that differentiate into DA neurons, since expression of 
the fluorescent reporter is driven by the TH promoter. 
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As shown in the result section, cells exposure to the action bFGF and Sonic 
Hedgehog (Volpicelli et al. 2004b) followed by the differentiation phase. 
Overexpressing, in single or double-combination, Mash1 and Nurr1 availing of 
inducible lentiviral vectors appears a reliable system to evaluate the effect of these 
genes on the expression of known dopaminergic markers and their hierarchical 
position in the differentiation network. 
That Nurr1 overexpression leads to an increase in TH expression was expected, from 
previous data in the laboratory and other published work while a major increase of 
TH transcripts led by co-overexpression of Mash1 was e new interesting result. 
Notably, this effect observable in both midbrain-derived as well as in cortex-derived 
cells, strongly indicate that there in these culture there is a relative loss of the 
regionalization specificity or that the effect of both factors on TH expression is 
regionalization-independent and does not require a specific dopamine-precursor 
cellular context.  
On the contrary the finding that other markers, normally expressed only in mature 
DA neurons, such as DAT, Vmat2 and the midbrain-specific Pitx3, is modified by 
Mash1 and Nurr1overexpression, albeit at low levels, only in midbrain-derived cells, 
is rather in favor of the hypothesis that only a proper cellular context allows these two 
transcription factors to sustain maturation of DA neurons. However, the low 
expression level of these markers shows that the cells are immature or still 
completing their differentiation at the stages analyzed.  
These observations prompted me to inquire how Mash1 and Nurr1 could cooperate in 
defining the DA phenotype, through the specific activation of TH expression. My 
hypothesis is strengthened by the observation that the overexpression of Mash1 alone 
led to a two-fold increase in TH expression only in midbrain-derived cells, where 
endogenous Nurr1 is present. Consistent with these observations, overexpression of 
the two TFs in the more stable mesencephalic cell line A1 led to comparable effects 
both on TH expression and on DA markers.    
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The immunochemistry experiments confirmed that the effect of Mash1 and Nurr1 co-
expression regulates the proper DA phenotype since TH-GFP+ cells are significantly 
increased in double-treated cultures compared with Nurr1-transduced cells. The 
Nurr1- and double-treated cells are undoubtly post-mitotic since by Tuj1 
immunostaining they have been found positive for the β−ΙΙΙ Tubulin, a characteristic 
marker of post-mitotic neurons. Intriguingly, the number of Tuj1+ cells is comparable 
between the single and double-treated cells, suggesting that the double infection did 
not further affect the number of neurons. Surprisingly not all the cells expressing the 
exogenous Nurr1 have been found positive by TH immunostaining; however, I show 
that the number of Nurr1+/ TH+ cells is increased by the co-expression of Mash1. This 
observation is consistent with a cooperative mechanism between the two TFs and 
raises the hypothesis that Mash1 could enhance the Nurr1-mediated transcription of 
TH, while it doesn’t have per se a direct transcriptional effect on the latter. 
This hypothesis can underlie two alternative models: 
1. Mash1 binds directly the transcriptional complex formed by Nurr1 on the 
NBRE sequence and modulates its activity in a direct manner. 
2. Mash1 binds to probably distal enhancer sequences modulating Nurr1 
activity in an indirect way, i.e. by recruiting chromatin-remodeling factors. 
Mash1 is indeed know to bind specific sequences (CANNTG) called E-box to 
modulate the transcriptional activity of a number of genes (Castro et al. 2006). Thus, 
I screened the TH promoter for the presence of putative binding sites by using a 
bioinformatics model which avails of position weight matrices (PWM) to find 
probable matches on a given input sequence. This analysis confirmed the presence of 
three significant binding sequences, TH1, TH2 and TH3 positioned respectively at -
2800 bp, -4700 bp and -7700 bp from the transcription start site.  
Their presence on the normal TH promoter in vivo was confirmed by chromatin 
immunoprecipitation (ChIP) experiment on E12.5 midbrain-derived chromatin. There 
is a modest enrichment of Mash1 on TH1 and TH2 binding sites but not in the more 
distal TH3 site.  
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This experiment supported the hypothesis of an indirect effect of Mash1 on Nurr1-
induced activation of TH transcription but did not exclude a direct cooperation 
between the two TFs. I examined this aspect evaluating the enrichment of Mash1 on 
the specific Nurr1 binding site (NBRE), by a luciferase assay. The results are in 
contrast to a direct cooperation model, since Mash1 does not show a significant 
enrichment on NBRE in vivo and the co-expression with Nurr1 does not have any 
additive effect on the expression of luciferase as compared with Nurr1 alone. I could 
thus conclude against the possible direct cooperation of Mash1 and Nurr1 on the 
NBRE site. 
In summary, my results show the existence of a cooperative effect of Mash1 and 
Nurr1 on the differentiation of NSCs towards dopaminergic phenotype. The 
combined action of the two TFs, drive the cells in the post-mitotic phase and leads to 
an increase in the expression of the rate-limiting enzyme TH in cortex- and midbrain-
derived NSCs. The effect is observable, at low levels, also on the expression of more 
mature DA markers as DAT, Vmat2 and Pitx3. In particular Mash1 enhances Nurr1-
induced activation of TH transcription by binding two distal enhancers on the TH 
promoter rather than by a physical interaction with Nurr1. This is consistent with a 
permissive rather than instructive role of Mash1 in the development of DA neurons. 
A possible hypothesis to address the nature of this cooperative mechanism is 
suggested by a recent publication which shows that Mash1 is able to act as a “pioneer 
factor” by recognizing a repressed state of the chromatin of a number of promoters 
and allowing the access of specific TFs to activate the transcription (Wapinski et al. 
2013). Further experiments will be needed to assess a presumed epigenetic role of 
Mash1 in TH transcription. 
Altogether, these data shed further light on the molecular mechanisms underlying the 
differentiation of dopaminergic neurons pointing out the vision of a complex 
hierarchic mechanism which is strictly controlled, at given time points and at 
different levels, by the interplay of different factors rather than just a sequential 
transcriptional activation. 
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A key challenge in stem cell biology is indeed to understand how the different cell-
fate options are selected in a heterogeneous population and how the adoption of a 
given lineage-decision is coupled to appropriate regulation of the alternative genetic 
pathways. Clearly, while we assume that a gene can only have an “on” and an “off” 
state, in reality gene expression can be graded giving rise to a large number of 
combinations. A new vision, highlighted by recent studies, considers the genetic 
networks associated with key properties, such as self-renewal or differentiation, as a 
landscape, that can exist in a limited number of solutions or “states”. In this way the 
nature of stem cells relationship to commitment, differentiation and lineage selection 
can be described as a transition through stable states, mathematically defined as 
attractors (Enver et al. 2009). From this point of view the differentiation towards a 
defined lineage can be interpreted as a transition from a stochastic phase to a 
deterministic phase. In other words, the casual transition to a stable genetic state may 
activate a hierarchic cascade of molecular events leading to a fully differentiated cell, 
somehow finding order in chaos or, in the words of Waddington, a canalization of 
development (Waddington 1957).    
The new information generated during my thesis will be useful not only for our 
understanding of transcriptional regulatory cascade underlying the midbrain DA 
neuron development, but also for future in vitro generation of functional DA neurons 
from stem and/or progenitor cells for cell therapy of Parkinson’s disease, which is 
caused by the loss of midbrain DA neurons. 
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6. LIST OF ABBREVIATIONS 
 
A  
AADC Aromatic L-amino acid decarboxylase 
ADHD  Attention deficit hyperactivity disorder 
Ahd2  Aldehyde dehydrogenase 2 
AK  Aphakia 
ALS  
 
Amyotrophic lateral sclerosis 
B  
Bcl-XL  B-cell lymphoma-extra large 
BDNF  Brain-derived neurotrophic factor 
bHLH  basic Helix-Loop-Helix 
BMP  
 
Bone morphogenic protein 
C  
cAMP  cyclic Adenosine monophosphate 
CDNF  Conserved dopamine neurotrophic factor 
ChIP  Chromatin immunoprecipitation 
CNS  Central Nervous System 
COMT  
 
Catechol-O-methyl transferase 
D  
DA  Dopamine 
DAR  Dopamine receptor 
DAT  Dopamine active transporter 
DCX  Doublecortin 
DIV  Days in vitro 
Dmrt5  Doublesex and mab-3-related transcription factor 5 
DOPAC  
 
3,4-dihydroxyphenylacetic acid 
E  
EAE Experimental Autoimmune Encephalomyelitis 
En  Engrailed 
ESC  
 
Embryonic Stem Cells 
F  
FGF8  Fibroblast Growth Factor 8 
FP 
 
 
 
 
Floor plate 
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G  
GDNF Glial cell line-derived neurotrophic factor 
GFRα GDNF family receptor alpha 
GPe  external Globus Pallidus 
GPi  
 
internal Globus Pallidus 
H  
HVA  
 
Homovanillic acid 
I  
iDA  induced Dopaminergic Cells 
iN  induced Neuronal cells 
IP  immunoprecipitation 
iPSC  
 
induced Pluripotent Stem Cells 
L  
L-DOPA  Levodopa 
LRRK2  
 
Leucine-rich repeat kinase 2 
M  
MAO  Monoamine oxidase 
Mb  Midbrain 
MCLp  Mesocorticolimbic pathway 
MHB  
 
Midbrain-Hindbrain boundary 
N  
Ngn1-2  Neurogenin 1-2 
NGS Normal goat serum 
NSA  Neurosphere assay 
NSC  Neural Stem Cells 
NSp  Nigrostriatal pathway 
Nurr1  
 
Nuclear Receptor Related 1 
O  
OB  
 
Olfactory bulb 
P  
PD  Parkinson’s disease 
Pitx3  Pituitary homeobox 3 
PKA  Protein kinase cAMP-dependent 
PNMT Phenylethanolamine N-methyltransferase 
PPN  Pedunculopontine Nucleus 
Ptc1  Patched1 
PWM  Position Weight Matrix 
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R  
RA  Retinoic Acid 
RRF  Retrorubral field 
RXR  Retinoid X receptor 
 
S  
SGZ  Subgranular zone 
SHH  Sonic hedgehog 
Smo  Smoothened 
SN  Substantia Nigra 
SNc  Substantia Nigra pars compacta 
SNr  Substantia Nigra pars reticulata 
STN  Subthalamic Nucleus 
SVZ  
 
Subventricular zone 
T  
TF  Transcription Factor 
TH  Tyrosine Hydroxylase 
TLR  Toll-like receptor 
TSS  
 
Transcription Start Site 
V  
VM Ventral Midbrain 
Vmat2  Vesicular monoamine transporter 
VTA Ventral Tegmental Area 
VZ  Ventricular Zone 
 
W  
WT Wild Type 
 
 
 
